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Abstract 
Even though the hallmark of bipolar disorder is recurrent episodes of elevated 
or depressed mood, mounting evidence suggests that cognitive impairment is 
a prominent characteristic of bipolar disorder. The heterogeneity and 
longitudinal trajectory of cognitive functioning are, however, poorly 
understood. Additionally, certain personality traits may play a role in 
psychopathological processes along with cognitive impairments. 
 
This thesis is based on six studies. Data were collected within the framework 
of St. Göran bipolar project, which is a longitudinal study of patients with 
bipolar disorder. Study I examined the clinical relevance of cognitive 
impairments and examined if cognitive abilities differ between bipolar disorder 
subtypes and healthy controls. Study II examined whether the correlation 
structure between various cognitive abilities differs between individuals with 
bipolar disorder and healthy controls. Study III examined if cognitive abilities 
differ between individuals with bipolar disorder with and without attention-
deficit hyperactivity disorder (ADHD). Study IV examined if long-term 
changes in cognitive functioning in individuals with bipolar disorder differ 
from normal aging. Study V examined if personality traits differ between 
individuals with bipolar disorder and healthy controls, as well as the 
association between personality traits and illness course. Study VI examined if 
the cognition/personality interface is altered in bipolar disorder, and if 
combining cognitive predictors with personality measures would enhance the 
understanding of the illness course.  
 
Results showed that cognitive impairments approached clinical significance 
for substantial minority of the patients on certain cognitive tests measuring, 
e.g., set shifting and inhibition (I). While the majority of bipolar disorder 
patients performed on par with healthy controls, a subgroup (30%) showed 
impairments concerning memory (II). Comorbid ADHD in bipolar disorder 
could not explain the cognitive heterogeneity in bipolar disorder (III). The 
cognitive trajectory over a 6-year period did not differ between individuals 
with bipolar disorder patients and healthy controls (IV). The personality 
profile differed between patients and healthy controls but had no prognostic 
value (V). However, differences in personality traits explained some of the 
variation in cognitive performance in individuals with bipolar disorder (VI). 
 
Keywords: bipolar disorder, cognition, cognitive function, impairment, 
neuroticism, personality, personality inventory, psychometrics, and 
multivariate data analysis.  
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Sammanfattning på svenska 
Bipolär sjukdom kännetecknas av återkommande kraftiga förskjutningar i 
stämningsläge och aktivitetsnivå. Sjukdomen som drabbar ungefär 2 procent 
av befolkningen orsakar stort lidande. Bipolär sjukdom är episodiskt 
förlöpande men förloppet varierar mycket mellan individer. Med adekvat 
behandling kan dock många leva symtomfria. Flertalet studier har emellertid 
påvisat varaktiga kognitiva nedsättningar hos individer med bipolär sjukdom. 
De flesta studier visar på stor heterogenitet avseende svårighetsgrad och 
omfattning av kognitiva nedsättningar vid bipolär sjukdom. Det är inte 
fastställt i vad mån kognitiva nedsättningar påverkar risken för återinsjuknande 
och sjukdomsprognos. Inte heller om kognitiva nedsättningar progredierar 
och i så fall vilka riskfaktorerna är. Vissa personlighetsegenskaper utgör en 
sårbarhet för utvecklingen av olika psykiatriska tillstånd. Personlighet kan även 
ha prognostisk betydelse för sjukdomens skiftande förlopp. Det finns olika 
uppfattningar om hur personlighet och kognitiv funktion samvarierar. 
 
Den här avhandlingen bygger på sex delstudier. Data är insamlade inom ramen 
för St. Görans bipolärprojekt, en longitudinell, prospektiv studie av patienter 
med bipolära syndrom. I studie I undersöktes skillnader avseende kognitiv 
funktionsförmåga mellan bipolär sjukdom typ I, typ II och friska kontroller. 
Därutöver undersöktes om de kognitiva nedsättningar man finner hos 
individer med bipolär sjukdom har någon klinisk relevans. I studie II 
undersöktes om korrelationsstrukturen mellan deltest i ett kognitivt testbatteri 
skilde sig åt mellan individer med bipolär sjukdom och friska kontrollindivider. 
I studie III undersöktes om individer som har både bipolär sjukdom och 
ADHD har annan kognitiv profil än individer med endast bipolär sjukdom. I 
studie IV undersöktes hur kognitiv funktion hos personer med bipolär 
sjukdom och friska kontrollpersoner förändrats efter sex år. I studie V 
undersöktes eventuella skillnader mellan patienter och kontroller avseende 
personlighetsegenskaper. Vidare undersöktes om utfallet i patientgruppen 
hade någon betydelse för sjukdomsförloppet de kommande två åren. I studie 
VI undersöktes gränssnittet mellan personlighet och kognition och huruvida 
det skiljde sig åt mellan individer med bipolär sjukdom och friska individer.  
 
Resultaten i studie I visade att kognitiva nedsättningar inte skiljer sig nämnvärt 
åt mellan bipolär sjukdom typ I och II. Nedsättningar avseende kognitiv 
flexibilitet, inhiberingsförmåga och processhastighet var kliniskt signifikanta 
för en minoritet av patienterna. Studie II visade att majoriteten av patienterna 
presterar i nivå med kontrollerna men att en betydande undergrupp har 
nedsättningar inbegripande olika aspekter av minne. Studie III visade att det 
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inte med hjälp av kognitiv testning går att särskilja patienter som har både 
bipolär sjukdom och ADHD från dem som endast har bipolär sjukdom. 
Resultaten i studie IV visade att kognitiv funktion inte försämras under en sex-
årsperiod hos individer med bipolär sjukdom relativt friska individer. Studie V 
visade att personer med bipolär sjukdom kännetecknas av övergenomsnittliga 
medelvärden på nästan alla delskalor i personlighetsinventoriet jämfört med 
friska individer, men att variation i personlighet saknade prognostiskt värde 
för sjukdomsförloppet två år framåt. Personlighetsegenskaper skilde sig inte 
åt mellan bipolär sjukdom typ I och II. Slutligen visade studie VI att sambandet 
mellan Neuroticism och prestation på en rad kognitiva tester var starkare hos 
individer med bipolär sjukdom än hos friska individer.  
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Introduction 
Studies on psychiatric conditions have traditionally focused on emotional 
symptoms, delusions, and abnormal behavior, but less on cognitive 
functioning despite the close relationship between cognition and 
psychopathology (Millan et al., 2012). For example, lower childhood IQ 
predicts several psychiatric disorders, e.g., schizophrenia and anxiety 
disorders, and greater psychiatric comorbidity in adulthood (Koenen et al., 
2009). In fact, cognitive impairments are part and parcel of psychiatric 
disorders that may impact quality of life and psychosocial functioning 
(Fourrier, Singhal, & Baune, 2019; Millan et al., 2012). Many severe psychiatric 
conditions are treated with drugs to alleviate some of the symptoms, e.g., 
anxiety or hallucinations. Yet, associated cognitive impairments do not 
improve to the same extent and may even worsen (Hill, Bishop, Palumbo, & 
Sweeney, 2010; Millan et al., 2012).  
 
I argue that cognitive functioning is a highly relevant dimension of psychiatric 
disorders that cuts across traditional diagnostic boundaries (Lai, Lombardo, & 
Baron-Cohen, 2014; Millan et al., 2012). 
 
Ever since Kraepelin’s diagnostic conceptions, remission without cognitive 
dysfunction has been considered the key feature separating manic-depressive 
illness from dementia praecox (i.e., schizophrenia) (Kraepelin, 1921). But we 
now know that individuals with bipolar disorder (BD) not only suffer from 
mood swings, but also struggle with impairments in cognitive functioning. 
Even though these cognitive deficits are most apparent during depression and 
mania, they might linger and contribute to functional deficits also during 
periods of remission (Kurtz & Gerraty, 2009; Martínez-Arán et al., 2004). 
 
Kraepelin (1921) also proposed that “there are certain temperaments which 
may be regarded as rudiments of manic-depressive insanity” which form “the 
point of departure for a morbid process” (p. 118). These are the moody 
‘depressive’ temperament, the hot-tempered ‘irritable’ temperament, and the 
impulsive ‘manic’ temperament. Moreover, he suggested that an individual’s 
temperament type to some extent predicted the nature and course of the 
illness.  
 
The standard classification of mental disorders used in current mental health 
services do not consider the notion that certain personality traits might impact 
illness course. The current categorical way of classifying psychopathologies 
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produces high incidence of ‘comorbid’ conditions. An alternative way of 
studying psychiatric conditions is based on dimensional models (Caspi et al., 
2014). A General Psychopathology dimension has been proposed, 
characterized by personality traits that hinder coping with other people, the 
environment, and the self. 
 
Personality and general cognitive ability are usually considered separate 
constructs (Maltby, Day, & Macaskill, 2007) and few attempts have been made 
to link them, in particular in the field of bipolar disorder.  
Bipolar disorder  
Conditions with clear fluctuations in mood states have been described ever 
since antiquity. Even though Jean Pierre Falret described ‘circular insanity’ in 
1854 (Pichot, 2004), Emil Kraepelin is considered to be the father of the 
diagnosis ‘manic depressive illness’ (Kraepelin, 1921), which is called bipolar 
disorder (BD) in current diagnostic systems. A wealth of portrayals, stories, 
that put flesh on the bones enable us to better understand lived experiences 
of individuals with BD. Virginia Woolf writes in her diary: “And now today 
suddenly the weight of my head is lifted and I can think, reason, keep to one 
thing and concentrate. Perhaps this is the beginning of another spurt. Perhaps 
I owe it to my conversation with L. last night. I tried to analyze my depression: 
how my brain is jaded with the conflict of two types of thought, the critical, 
the creative; how I am harassed by the strife and jar and uncertainty without. 
This morning the inside of my head feel cool and smooth instead of strained 
and turbulent” (Woolf, 1977, p. 181). BD is associated with a great deal of 
suffering and should not be romanticized, but nuances are warranted. There 
is a disproportionate rate of BD in creative individuals (Koutsantoni, 2012; 
Kyaga et al., 2011), which is important to keep in mind when examining 
individuals from the psychiatric vantage point.  
Subtypes of bipolar disorder 
There are subtypes of bipolar disorder. The essential features of bipolar I 
disorder is the occurrence of one or more manic or mixed episodes (DSM-IV-
TR, 2000). More often than not, afflicted individuals also suffer one or more 
major depressive episodes during the course of illness. Manic episodes are 
characterized by abnormally elevated mood and increased motor drive and 
approximately 75% of all patients show psychotic symptoms during an acute 
manic episode (Grande, Berk, Birmaher, & Vieta, 2016). Mixed episodes can 
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also be present in BD I and are characterized by a combination of depressive 
and manic symptoms that occur every day for a week.  
 
Bipolar II disorder is characterized by the occurrence of one or more major 
depressive episodes, accompanied by at least one hypomanic episode (DSM-
IV-TR, 2000). A hypomanic episode presents with persistently elevated, 
expansive, or irritable mood during at least four days, but hypomanic 
symptoms do not cause severe impairments in every day functioning. A history 
of a full blown manic or mixed episode precludes the diagnosis of bipolar II 
disorder.  
 
Both subtypes of BD present with symptoms that taken together cause 
clinically significant distress or impairment in social, occupational, or other 
important areas of functioning. Mood episodes induced by medication, drug-
use, or toxin exposure do not count towards a diagnosis of BD. Also, the 
episodes should not be better explained by schizoaffective disorder, 
schizophrenia, or other psychotic disorders.  
 
BD not otherwise specified (NOS) includes disorders with bipolar features that do 
not meet criteria for any specific BD mentioned above, e.g., recurrent 
hypomanic episodes without depressive symptoms, or periods with 
hypomanic symptoms that do not meet the duration requirement of a 
minimum of 4 days (DSM-IV-TR, 2000).  
 
The word euthymia originates from Greek and combines the words ‘eu' 
meaning ‘well' and ‘thymo' meaning ‘soul, emotion'. It refers to the state in-
between recurring mood episodes, so called free intervals. When an individual 
with BD do not meet criteria for a hypomanic, manic, mixed, or depressive 
episode, they are considered to be euthymic or well (Fava & Bech, 2016). 
Periods of euthymia is a prerequisite for an episodic illness.  
 
Cyclothymic disorder present with chronic, fluctuating mood episodes involving 
subthreshold hypomanic, or hypomanic, and depressive symptoms for at least 
two years (DSM-IV-TR, 2000). The hypomanic and depressive symptoms are 
not sufficient to meet full criteria for mania or depression.  
 
Moreover, bipolar spectrum concepts have been proposed (Akiskal et al., 2006; 
Angst, 2007), which are described more thoroughly in the personality section. 
 
  
 
18 
Patients included in the St. Göran bipolar project went through a systematic 
diagnostic examination according to Diagnostic and Statistical Manual of 
Mental Disorders, 4th. Edition, Text Revison (DSM-IV-TR). For a more 
detailed description of the diagnostic evaluation, please see the method 
section. 
Prevalence  
The total lifetime prevalence has been estimated to 0.6% for bipolar I disorder, 
0.8% for bipolar II disorder, and 1.4% for subthreshold bipolar disorder 
(Merikangas et al., 2007). This sums up to a total prevalence of 2.8% for 
bipolar spectrum diagnoses, which means that about 147 million people would 
be affected worldwide. However, the study by Merikangas and colleagues 
(2007) suggested that the prevalence varies across countries ranging from 0.1% 
(India) to 4.8 (USA). According to the DSM-IV, it is equally likely that men 
and women are affected by bipolar I disorder (DSM-IV-TR, 2000). On the 
other hand, the WHO´s World Mental Health Survey Initiative from 2007 
showed that lifetime rates of bipolar I disorder and subthreshold BD were 
larger in males than in females (Merikangas et al., 2007). Bipolar II disorder is 
considered more common in women than in men (DSM-IV-TR, 2000).  
Illness course  
The average age at onset for BD is 20 years for both men and women (DSM-
IV-TR, 2000). However, individuals with first-degree relatives with mood 
disorders are more likely to have an earlier age at onset. More than 90% of all 
individuals that have one mood episode go on to have future episodes. About 
60-70% of all manic episodes and hypomanic episodes occur immediately 
before or after a depressive one. According to the kindling hypothesis, relapses 
in mood episodes get gradually less influenced by life stressors with time spent 
ill, and the intervals between episodes tend to shrink as the individual ages 
(Grande et al., 2016). This not only warrants early detection of the disorder 
but also stresses the need for prophylactic treatment to prevent episodes. 
 
Kessler et al. (2006) investigated a large sample of US workers and showed 
that approximately three quarters of individuals with BD had depressive 
episodes during a 12-month period, and 60% had manic-hypomanic episodes 
(Kessler et al., 2006). On average 98 (median 60) days were spent in a 
depressive episode during a year. These numbers differ substantially from the 
Swedish National Quality Register for Bipolar Disorder (BipoläR) where 
approximately 38% of individuals with BD had any depressive episode during 
a 12-month period (2018), and 28% had any manic-hypomanic episode. Of 
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note, the illness course of BD has changed with modern medical treatment 
(Angst & Sellaro, 2000). Data from the days before modern medical treatment 
suggest that the length of manic episodes had a median duration of 5–6 
months. A common cause of relapses today is non-adherence to medication 
(Colom, Vieta, Tacchi, Sánchez-Moreno, & Scott, 2005). Co-occurring 
psychiatric diagnoses are also a risk factor (BipoläR Årsrapport, 2014). In any 
type of BD, the premenstrual period may be associated with worsening of a 
mood episode (DSM-IV-TR, 2000). 
 
Models of the ‘staging hypothesis’ suggest that the illness course move along 
a progressive path with loss of psychosocial functioning in the prodromal 
phase, and with cognitive decline in the later stages of the illness (Berk, 2009; 
Berk et al., 2017; Grande et al., 2016; Kapczinski et al., 2014). 
 
BD is a potentially deadly condition: completed suicides occurs in 10-15% of 
all individuals with bipolar I and II disorder (DSM-IV-TR, 2000). A Swedish 
population-based study from 2001 showed that the standardized mortality 
ratios for suicide in BD were 15.0 for males and 22.4 for females, while 
corresponding numbers for unipolar depression were 20.9 and 27 (Ösby, 
Brandt, Correia, Ekbom, & Sparén, 2001). The suicide mortality rate was most 
evident at younger ages and adjacent to receiving a diagnosis.  
Familial pattern 
Bipolar disorders tend to run in families and are highly heritable. In a Swedish 
population-based study, the heritability (the portion of illness accounted for 
by genetic factors) for BD was estimated to 59% (Lichtenstein et al., 2009). 
Childhood shared environmental effects was estimated to 3.4% and non-
shared environmental effects to 38%. This study also showed that 
schizophrenia and BD partly shared genetic risks. Interestingly, ADHD and 
BD has also been shown to share genetic factors (Larsson et al., 2013). Other 
twin and family studies have arrived at slightly higher heritability estimates, 
where genetic influences explain 80-85% of the risk (Barnett & Smoller, 2009). 
Hence, even though genetic variation accounts for most of the population risk, 
the etiology of BD is complex and multifactorial.  
Common co-occurring conditions  
Several other psychiatric disorders present with fluctuations in mood and 
activity level and BD needs to be differentiated from, e.g., ADHD and 
borderline personality disorder. In addition, a majority of individuals with BD 
also meet life time criteria for other psychiatric disorders (Table 1). The high 
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number of comorbidities begs the question whether some of these comorbid 
conditions are actually distinct disorder or merely show that individuals with 
BD present a plethora of symptoms that fulfill criteria for several diagnoses. 
Thus, the high comorbidity is likely to not only reflect true comorbid 
conditions but also to be a diagnostic artefact from using a categorical 
diagnostic system (Wittchen, 1996).  
 
The 12-month prevalence for attention-deficit/hyperactivity disorder 
(ADHD) among 8- to 15-year old US children is 9 percent (Merikangas et al., 
2010). In Sweden, ADHD occurs in approximately every 20 children (Gillberg, 
Fernell, & Råstam, 2015). The criteria for adult ADHD are met for at least 
half of those who met diagnostic criteria in childhood. The prevalence rates 
of individuals suffering from both ADHD and BD varies across different 
studies (Table 1). One explanation could be that ADHD and BD present with 
some similar symptoms, which might complicate diagnoses. A possible 
consequence is that the comorbid condition BD+ADHD is under-diagnosed 
and under-treated (Klassen, Katzman, & Chokka, 2010). It is important to 
identify individuals with co-occurring BD+ADHD as they present with more 
severe illness course and lower every day functioning. Interestingly, an earlier 
study conducted on the SBP-cohort showed that individuals with BD who 
met the criteria for childhood ADHD, but did not fulfil criteria for adult 
ADHD, also showed worse illness course than individuals with BD without a 
history of ADHD (Rydén et al., 2009). 
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Quality of life and functioning  
Bipolar disorder is one of the most debilitating disorders in the developed 
world according to the World Health Organization (WHO, 2004). ‘Quality of 
life’ is rarely defined in the literature of BD (Morton, Michalak, & Murray, 
2017). However, the most common definition was coined by the WHO: “an 
individual's perceptions of their position in life in the context of the culture 
and value systems in which they live and in relation to their goals, expectations, 
standards and concerns” (The WHOQOL Group, 1995). Impairment in 
psychosocial functioning, i.e., a person’s ability to perform activities of daily 
living and to engage in meaningful interpersonal relationships, is a significant 
feature of BD even during euthymia (Michalak & Murray, 2010). Occupational 
functioning is an important aspect of psychosocial functioning and reduced 
among individuals living with BD (Bonnín et al., 2014; Gilbert & Marwaha, 
2013; Mur, Portella, Martinez-Aran, Pifarre, & Vieta, 2009; Ryan et al., 2013). 
Individuals living with BD are more often unemployed compared not only to 
the general population but also in comparison to people suffering from 
Table 1 
Common life-time co-occurring developmental  
and psychiatric conditions in BD subtypes   
 Life-time co-occurring developmental and psychiatric conditions 
Condition  BD-I  
% 
BD-II 
% 
Comments  
Developmental:    
ADHD 28 28 In the SBP-cohort 16 % of all patients with BD 
met the criteria for ADHD (Rydén et al., 2009). 
Psychiatric:     
Any anxiety disorder  77 75  
Any substance use disorder  52 35  
Alcohol dependence  31 17  
Drug dependence  24 8  
Suicide attempts  26 21  
Self-mutilation 38 27 Interestingly, most commonly observed in 
subjects with bipolar I disorder (Joyce, Light, 
Rowe, Cloninger, & Kennedy, 2010) 
Borderline personality 
disorder  
10 20 (Zimmerman & Morgan, 2013) 
 
PTSD  21  16 (Hernandez et al., 2013) 
Prevalence rates from (Merikangas et al., 2011) unless specified in comments 
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unipolar depression. Moreover, people with BD who remain employed might 
gravitate toward less demanding work roles (Marwaha, Durrani, & Singh, 
2013). However, there is a significant heterogeneity in functioning among 
individuals with BD ranging from high functioning individuals to people with 
large impairments in multiple domains (Solé et al., 2018). Factors that have 
been linked to the functional outcome in BD are co-occurring psychiatric 
conditions (Hajek et al., 2005; Zimmerman et al., 2010) and impaired cognitive 
functioning (O’Donnell et al., 2017)  
Treatment  
Common medications used to treat bipolar disorder include mood stabilizers, 
atypical antipsychotics, and antidepressants (Sachs, Printz, Kahn, Carpenter, 
& Docherty, 2000). Lithium has been used for decades and is the first-line 
treatment in BD as it effectively prevents manic and depressive mood episodes 
(Joas et al., 2017) as well as suicidal behavior (Song et al., 2017). In Swedish 
psychiatric care, virtually all individuals with BD are prescribed some 
medication (Persson et al., 2017). A significant majority of individuals in both 
type I and type II BD groups use mood stabilizing drugs. According to data 
from the Swedish national quality register BipoläR, two-thirds of the type I 
BD group received lithium treatment, and the second most common mood-
stabilizing drug was lamotrigine. In type II BD, lamotrigine was the most 
commonly prescribed mood-stabilizing drug and lithium was the second most 
common. Lamotrigine was twice as common in type II as in type I. Nearly half 
of the subjects with bipolar I disorder and over one-third of bipolar II disorder 
subjects were treated with an antipsychotic drug. Over one-third of the 
subjects with bipolar I disorder and over half of bipolar II disorder subjects 
used an antidepressant. Medical treatment used for ADHD have increased 
dramatically during recent years and are twice as common in patients with 
bipolar II disorder compared with bipolar I disorder, whereas benzodiazepines 
or benzodiazepine-like drugs are more common among individuals with 
bipolar I disorder. Differences in medication were significant even after 
adjusting for age, sex, and co-occurring anxiety and substance use disorders. 
Sex differences in treatment have been demonstrated in routine clinical 
settings in Sweden; women were more frequently treated with antidepressants, 
lamotrigine, electroconvulsive therapy, benzodiazepines, and psychotherapy 
whereas men were more often treated with lithium (Karanti et al., 2015). 
 
There is emerging evidence of the benefits of adding psychosocial 
interventions and psychotherapies to drug treatment in BD (Geddes & 
Miklowitz, 2013; Swartz & Swanson, 2014). The most common interventions 
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are summarized here. Psychoeducation aims to improve illness insight, to make 
patients better in understanding and detect early symptoms, and to develop 
coping strategies Francesco Colom et al. (2003). Specific group 
psychoeducation programs have been shown to be effective in reducing the 
number of relapses and the number and length of hospitalizations, but also in 
increasing the length of euthymic intervals (Colom & Vieta, 2006). We recently 
found that psychoeducation reduces the risk of mood episodes and inpatient 
care also when implemented in routine clinical practice (Joas et al., 2019, in 
press). Interpersonal and social rhythm therapy assumes that individuals with BD 
have disturbances in both circadian rhythm and sleep–wake cycles (Frank, 
Swartz, & Kupfer, 2000). This specific therapy focuses on identification of life 
events (both negative and positive) that might cause irregular sleep-wake 
rhythms, which in turn lead to mood symptoms. Cognitive Behavior Therapy 
(CBT) approaches has also been developed (Scott et al., 2006), with a broad 
repertoire of interventions aiming at acceptance of the disorder, reducing 
irregularity in mood symptoms, and identifying psychosocial stressors and 
interpersonal problems that may increase the risk of mood episodes. But CBT 
also teach coping strategies and aims to change dysfunctional automatic 
thoughts.  Family focused therapy contains an extensive program that involves 
family members and includes psychoeducation, communication enhancement 
training, and problem-solving skills (Miklowitz, George, Richards, Simoneau, 
& Suddath, 2003). Family focused therapy has been shown to increase the 
length of euthymic intervals.  
Cognitive functioning  
Cognitive function can be defined as a “general mental capability involving 
reasoning, problem solving, planning, abstract thinking, complex idea 
comprehension, and learning from experience” (Gottfredson, 1997). Different 
aspects of cognitive functioning can be measured with different cognitive 
tests. “Neuropscyhological assessment is, in short, a means of measuring in a 
quantitative, standardized fashion the most complex of human behavior – 
attention, perception, memory, speech and language, building and drawing, 
reasoning, problem solving, judgment, planning, and emotional processing” 
(Lezak, 2012, p. 15). 
Individual differences in intelligence  
Differences in intelligence are partly heritable (Deary, 2013). The proportion 
of differences in intelligence explained by genetic factors is approximately 20% 
– 30% in childhood and increases to as high as 70% – 80% in midlife (Deary, 
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Johnson, & Houlihan, 2009). Polygenic scores derived from genome-wide 
association studies (GWAS) of intelligence can currently predict 4% of the 
variance in intelligence (Plomin & von Stumm, 2018). Individual differences 
in intelligence profoundly impact people’s lives as it predicts success in major 
life areas, e.g., work, education, social life, and everyday functioning 
(Gottfredson, 1997). 
The g-factor  
Healthy people who perform well on one cognitive test tend to perform well 
on a wide range of other tests. In other words, different tests of cognitive 
function are positively correlated (Deary et al., 2009). This pattern is seen when 
a large group of people are tested with several different cognitive tests. This 
phenomenon is known as general intelligence, general mental ability, or 
general cognitive ability, g for short. Spearman showed already in 1904 that a 
person’s g accounts for about half of the inter-individual differences in 
cognitive ability. Some individual tests correlate more closely to each other 
and therefore represent different domains, e.g., processing speed and 
perceptual functioning. However, these domains are also highly correlated 
(Deary, Penke, & Johnson, 2010). Actually, independently from g, the main 
types of mental abilities in which people differ are those that are specific for 
individual tasks (Carroll, 1993). In summary, as long as a satisfactory number 
of tests are given to a group of people, any group will produce a g-score that 
is not unique for the tests given. Hence, the resulting g-score would be the 
same with almost any choice of tests. Nevertheless, certain single tests, e.g., 
the Raven test, appear to be particularly reliable in indicating general 
intelligence (Deary & Batty, 2007).  
 
Different psychometric models of human intelligence have been suggested 
(Johnson & Bouchard Jr, 2005). Notably, it has been suggested that executive 
functioning is not related to g. Individuals with frontal lobe damages with poor 
results on tests measuring executive functioning show unaffected results on 
intelligence tests such as WAIS-III (Friedman et al., 2006). Executive 
functioning is not a uniformly defined construct but is usually separated into 
three categories: shifting, updating, and inhibiting (Friedman et al., 2006). 
Friedman et al., (2006) demonstrated that both inhibiting and shifting are 
weakly coupled to general intelligence whereas updating was more closely 
related. The working memory construct reflects the storage component and 
the central executive or attention component. Working memory is believed to 
be related to g: Engle et al. showed that working memory – but not short-term 
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memory – was strongly associated with fluid intelligence (Engle, Laughlin, 
Tuholski, & Conway, 1999). 
Life course 
Intelligence shows substantial stability across the life course in healthy persons 
(Deary et al., 2009). According to Deary (2009), aging breeds an essential 
difference between two types of intelligence, fluid and the crystallized 
intelligence. Fluid intelligence concerns comprehending and figuring out 
problems there and then. Crystallized intelligence concerns retrieval of well-
established knowledge such as vocabulary or general knowledge. Fluid 
intelligence show age-related cognitive decline while crystallized intelligence 
shows little age-related decline. The mechanism of cognitive decline is well 
characterized even though it might be difficult to separate non-pathological 
from pathological cognitive decline (Deary et al., 2009). Age affect the variance 
shared by all tests but in particular processing speed and memory (Deary 
2013). Therefore, tests that capture vocabulary knowledge is often used to 
estimate premorbid functioning, for example the National Adult Reading Test 
(NART) (Blair & Spreen, 1989). 
Ecological validity of cognitive tests 
Historically, cognitive tests were developed to identify brain damage (Chaytor 
& Schmitter-Edgecombe, 2003). With time, the type of questions asked by 
clinicians have shifted focus from brain damages to assess real-world 
functioning in school or at the work place. Chaytor (2003) defined ecological 
validity as follows: “the degree to which results obtained in controlled 
experimental conditions are related to those obtained in naturalistic 
environments” (from Tupper and Cicerone, 1990). The extent to which a 
cognitive test reflects an individual’s real-world functioning is hence called 
ecological validity. The construction of tests has changed since the aim of 
assessment no longer is to discriminate brain-injured from normal individuals. 
A recurring problem is the lack of consensus concerning what a test actually 
measures. Two clinicians may have different aims with administering the same 
test. With respect to measuring the loosely defined construct of executive 
functioning, it has been shown that self-reports in fact predict impaired real-
world functioning better than tests aimed at assessing executive functioning 
(Barkley & Fischer, 2011). 
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Cognitive impairment 
Cognitive impairment is difficult to define. There is no established threshold 
that define impairment in clinical practice. It depends on contextual factors 
such as premorbid ability, but also on what one can expect the progress to be 
(Cullen et al., 2016; Roux et al., 2019). The presumed cause of impairment also 
matters. The term ‘mild cognitive impairment’ (MCI) is for example seldom 
used in the bipolar disorder field. There are various subtypes of MCI with 
different etiologies,  yet the concept is tightly coupled to the thought of 
progression (Petersen et al., 2009).  
 
In study I of this thesis, the clinical significance of cognitive 
impairments in bipolar disorder is investigated. 
Cognitive impairments in bipolar disorder  
One of the first studies on cognitive impairment in bipolar disorder was 
carried out more than 20 years ago in Sweden. Anne Tham and colleagues 
(1997) investigated neuropsychological performance in euthymic patients with 
recurring mood disorders. They showed overall lowered test results and 
suggested a subgroup of patients defined by more relapses and episodes of 
hospitalization showing cognitive dysfunction even when euthymic. Ever 
since, several numbers of studies have shown that cognitive impairment 
persist during euthymia. The last fifteen years has seen meta-analyzes 
conducted on cross-sectional studies in the field (Arts, Jabben, Krabbendam, 
& Van Os, 2008; Bora,Yucel, & Pantelis, 2009; Krabbendam, Arts, van Os, & 
Aleman, 2005; Robinson et al., 2006; Torres, Boudreau, & Yatham, 2007). By 
and large, these analyses find group level differences in global measures across 
broad cognitive domains such as processing speed, attention, different 
memory tests, and executive functioning.  
 
In response to the lack of consensus in the field and discrepancies across 
studies, a reanalysis was made in 2013 comprising data from 31 studies on 
cognitive functioning in BD. This time the analysis controlled for important 
baseline factors such as age, IQ, and sex (Bourne et al., 2013). Authors found 
that cognitive deficits remained significant after adjusting for these factors. 
They showed that individuals with BD had small to moderate effect sizes on 
established differences in performance on all 11 outcome measures from 4 
selected neuropsychological tests (verbal learning, Trail Making Test, Digit 
span, and Wisconsin Card Sorting Test). They also found that lingering minor 
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depressive symptoms and the effects of some drug treatments may contribute 
to differences compared with controls, but could not fully explain them. 
 
Taken together, group-level mean differences between individuals with BD 
and healthy controls (HC) have been reported. Large effect sizes tell us there 
are large differences between groups. Nevertheless, it does reveal the 
proportion of adults with BD with clinically relevant cognitive impairment. It 
is possible that group mean differences harbor a significant within-group 
variation, ranging from normal performance to severe impairment in BD. It is 
also possible that some individuals suffer from specific impairments and some 
suffer from multi-domain impairments. If the overall group differences are 
being driven by a subgroup of patients with marked levels of impairment, this 
would obscure the true picture of cognitive impairment in the BD population, 
which may be severe for some and absent for others. Heterogeneity in 
cognitive function in BD has been investigated with regard to clinical 
subphenotypes, as well as heterogeneity in cognitive functioning in the BD 
population. (Iverson, Brooks, Langenecker, & Young, 2011; Martino et al., 
2008).  
 
In study I and III, we investigated clinical subgroups with respect to 
cognition and in study II we investigated the possibility of cognitive 
subgroups in BD.  
 
It is also possible that mean group differences are a result of case-mix 
differences or demographic differences. To exemplify this, we compared 
individuals with BD with another group of individuals with BD, all of them 
included in the St. Göran Bipolar Project, but in two different Swedish cities. 
Patients underwent the same systematic diagnostic examination procedure and 
followed the same study protocol. We found that the bipolar disorder groups 
differed significantly in Full scale IQ (FSIQ) between the cities. Individuals 
with BD in Stockholm performed significantly better (M = 106, SD = 14) than 
individuals with BD in Gothenburg [M = 98, SD = 13, t(270) = -5.023, p<.001, 
partial η2=0.086]. Individuals with BD in Stockholm also had significantly 
higher education level than individuals with BD in Gothenburg (p<0.001).  
 
The majority of studies in this field conduct mean group analysis to investigate 
differences in cognitive impairments. Using the same approach, we could 
assert that BD patients in Gothenburg are cognitively impaired compared with 
the same patient group in Stockholm. Needless to say, this might be explained 
by case mix differences.  
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Based on the fact that individual cognitive low-level cognitive abilities, i.e., the 
performance on individual tests as opposed to domain level, are positively 
correlated in a typical pattern, we argue that multivariate projection techniques 
are a better way to detect cognitive impairments across groups. Such 
techniques make it possible to identify individuals that deviate from 
expected/in comparison with healthy controls.  
 
In study II of this thesis, we examined whether the correlation 
structure between various cognitive abilities differs between 
individuals with bipolar disorder and healthy controls. 
Long term trajectory of cognitive functioning in bipolar disorder 
The construct of staging in bipolar disorder rests on the hypothesis that 
psychopathology moves along a progressive path, where a decline in cognitive 
impairment is seen in the later course of the disorder (Berk et al 2017). The 
paradigm of accelerated aging suggests that patients with BD experience 
accelerated cognitive decline in older days compared with a healthy population 
(Rizzo et al., 2014). Decreased levels of Brain-Derived Neurotrophic Factor, 
Oxidative stress, and vascular burden are some factors that have been 
suggested to be associated with cognitive impairments in elderly individuals 
with BD (Andreazza et al., 2015; Gildengers et al., 2010; Soares et al., 2016). 
A recent review show that history of BD significantly increases the risk of 
dementia in older adults (Diniz et al., 2017), a risk that increases with the 
number of episodes in depressive and bipolar affective disorders (Kessing et 
al., 2004).   
 
An important limitation of our knowledge and understanding of this episodic 
and potentially progressive disorder is that most research is based on cross-
sectional studies. Considering the limited numbers of long-term studies, it is 
as yet undecided whether BD has a progressively deteriorating course of 
cognitive functions or not.  
 
In study IV of this thesis, we investigated the trajectory of cognitive 
function in bipolar disorder over 6 years. 
How can cognitive impairments be explained?  
Genetic factors do not fully explain cognitive impairments seen in psychiatric 
disorders (Millan et al., 2012).  To understand the etiology, developmental and 
environmental factors must also be considered. For example, uncontrolled 
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stress and hypothalamic–pituitary–adrenal axis overactivity can prompt 
cognitive impairments across the lifespan. 
 
Efforts have been made to compile potential causes of cognitive impairments 
in the field of bipolar disorder. Savitz and colleagues (2005) pointed out the 
following potential causes: (i) iatrogenic, (ii) acute functional changes 
associated with depression or mania, (iii) permanent structural lesions of a 
neurodegenerative origin, (iv) permanent structural lesions that are 
neurodevelopmental in origin, and (v) permanent functional changes that are 
most likely genetic in origin. I will outline evidence for each of these potential 
causes below: 
 
(i) Roux and collauges (2019) found in accordance with Bourne (2013) an 
association between antipsychotic medication and cognitive impairment. 
Moreover, our research group found a negative effect of antipsychotic 
medication after controlling for the effect of psychotic episodes (Pålsson et 
al., 2013). Long-term use of benzodiazepines has also been associated with 
cognitive impairment (Barker, Greenwood, Jackson, & Crowe, 2004). 
Interestingly, it has been showed that tapering benzodiazepine use among 
long-term users can significantly improve cognitive performance without any 
substantial negative effects on subjective well-being or psychosocial 
functioning (Baandrup, Fagerlund, & Glenthoj, 2017). A meta-analysis 
showed that lithium carbonate had mild negative effects on some aspects of 
memory and creativity, and moderate effects on psychomotor performance in 
patients with euthymic affective disorders (Wingo, Wingo, Harvey, & 
Baldessarini, 2009). However, there were no differences in cognitive 
performance between healthy volunteers who received lithium and those who 
received a placebo, which imply that the association in patients might have 
been confounded by indication. The impact of anticonvulsants on cognition 
in individuals with BD have not been determined. Cognitive side effects has 
been shown to be less prominent in patients receiving lamotrigine compared 
with patients on valproate or carbamazepine (Daban et al., 2006). To 
complicate matters further, the majority of individuals with BD are on 
combinations of drug treatments. 
 
(ii) Cognitive functioning may be state-dependent as cognitive impairments 
are more pronounced during affective episodes of the illness course than when 
patients are euthymic (Martínez-Arán et al., 2004). Bourne (2013) showed that 
residual mood symptoms were associated with lower performance on some 
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cognitive tests, but the effect sizes were low. No association was detected 
between mania scores and a dozen of cognitive tests. 
 
(iii) In line with the construct of staging in BD, a decline in cognitive 
impairment has been demonstrated late in the course of the disorder (Berk, 
2009; Berk et al., 2017). And in line with the paradigm of accelerated aging, 
individuals with BD experience accelerated cognitive decline in old age 
compared with a healthy population (Rizzo et al., 2014). Cognitive impairment 
has also been associated with illness severity indices (Bora, 2018; Sanchez-
Morla et al., 2018) such as prior psychotic manifestations (Savitz, van der 
Merwe, Stein, Solms, & Ramesar, 2009), and the number of affective episodes, 
particularly manic episodes (Mann-Wrobel, Carreno, & Dickinson, 2011).  
 
(iv) ADHD and BD co-occur and there is a genetic overlap between the two 
diagnoses (Larsson et al., 2013; van Hulzen et al., 2017). Individuals with co-
occurring conditions are under-diagnosed as well as under-treated (Klassen et 
al., 2010). Comorbid ADHD is seldom controlled for in analyzes of cognition 
in BD, c.f., Bourne (2013) and Roux (2019). 
 
(v) First-degree relatives to individuals with BD present with cognitive 
impairments. In fact, executive functioning and verbal memory have been 
suggested as candidate endophenotypes for the genetic liability for BD (Arts, 
Jabben, Krabbendam, & van Os, 2011; Bora, Yucel, & Pantelis, 2009).  
Consequences of impaired cognitive functioning 
Cognitive dysfunction negatively impacts educational, occupational, and 
domestic functioning (Bonnín et al., 2014; Depp et al., 2012; Gilbert & 
Marwaha, 2013; Mur et al., 2009; Ryan et al., 2013). Executive dysfunction in 
particular has been linked to poor occupational functioning (Bonnín et al., 
2014; Gilbert & Marwaha, 2013; Mur et al., 2009; O’Donnell et al., 2017; Ryan 
et al., 2013).  
Therapeutic approaches for cognitive impairments   
A number of pharmacological interventions have been tested to treat cognitive 
impairments without conclusive results. There is currently no drugs approved 
to treat cognitive impairments in bipolar disorder (Sanches, Bauer, Galvez, 
Zunta-Soares, & Soares, 2015). Nonpharmacological interventions on the 
other hand, for instance functional remediation that not only target cognitive 
impairments but also poor functioning, have showed some promising results 
(Martínez-Arán et al., 2011; Vieta, Torrent, & Martínez-Arán, 2014).  
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Personality  
Rooted in Hippocrates theories of four humours: chole (yellow bile), 
melanchole (black bile), sanguis (blood) and flegma (phlegm), the Greek 
physician Galen explained differences in individuals in temperamental terms 
(Stelmack & Stalikas, 1991). It was thought that imbalance in different 
humours, temperaments, or psychological dispositions lead to mental 
problems. In modern times, a variety of theories have been developed to 
understand how personality constitutes are linked to psychic suffering, e.g., 
psychoanalytic, humanistic, and cognitive theories (Freud, 1983; Rogers, 1956; 
Watson, 1913). Thus, the concept of personality is multifaceted and based on 
various theoretical basic assumptions.  
Fundamental states  
Kreapelin (1921) postulated that there are “certain temperaments” which may 
be regarded as “rudiments of manic depressive insanity”. “They may 
throughout the whole of life exist as peculiar forms of psychic personality 
without further development; but they may also become the point of departure 
for morbid process which develops under peculiar conditions and runs its 
course in isolated attacks” (Kraepelin, 1921, p. 118). The “depressive 
temperament” is characterized by a “permanent gloomy emotional stress in all 
experiences of life” (p.118). In this patient group, mood is predominantly 
depressed and accompanied by a weak feeling of guilt, anxiety, and a lack of 
self-confidence. Kraepelin describes these individuals as experiencing 
interrupted series of “periodic melancholia”, suddenly interrupted by periodic 
mania. The “manic temperament” is regarded as the antithesis of the 
depressive temperament. In these individuals, mood is exalted and they tend 
to act carelessly and with great confidence. In addition, they are restless, 
charming, and live in constant feud. The slightly hypomanic states might 
develop into pronounced hypomania with rare attacks of pure depression. The 
“irritable temperament” is best explained as a “mixture of fundamental states” 
(Kraepelin, 1921, p. 130). These individuals are easily offended; the mood is 
subject to frequent change and they are impulsive. Additionally, they come too 
easily to delusional interpretations of life events. Lastly, the “cyclothymic 
temperament” is characterized by “frequent, more or less regular fluctuations 
of the psychic state to the manic or to the depressive state” (Kraepelin, 1921, 
p. 131). These individuals can be sparkling and full of joy, and after some time 
they become blue, ill-humored, and again after few months they are full of 
energy again. In the beginning of their illness course they have short-lived 
passing attacks that with time tend to turn more frequent and long lasting. 
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The trait concept  
Words to describe people in general constitutes the foundation for 
conceptualizing modern personality traits (Cattell, 1943). In the ambitious 
work of Cattell, four to five thousand words were categorized into about 160 
categories. This semantic reduction was made with correlation statistics and 
yielded clusters of related words. The work took place entirely within the 
framework of normal psychology. Since the 1940s, the personality field has 
attempted to determine the optimal number of categories – traits – necessary 
to account for the variation in a person's styles of behavior in different 
cultures. “Traits refer to stability of behavior and beliefs about enduring 
dispositions” (Matthews, Deary, & Whiteman, 2009, p. 85). Assessment of 
traits is often conducted with self-rating questionnaires. 
 
Temperaments are constructs partly separated from traits and can be described 
as biologically rooted, observable, behavior tendencies that emerge early in life 
and are stable to a certain degree while undergoing a socialization process 
(Matthews et al., 2009).  
 
Stable traits and transient states are also separate constructs, and measured 
separately. States “refer to any reliably measurable characteristics, but typically, 
state variables refer to conscious, verbally reportable qualities such as moods” 
(Matthews et al., 2009, p. 85). Unlike trait tests, state tests should not show 
high retest reliability.  
 
Eysenck (1984) proposed a tridimensional model with biological roots: 
Extraversion-Introversion, Neuroticism, and Psychoticism. Costa and McCrae 
(1992), on the other hand, organized personality into five factors: Neuroticism 
(N), Extraversion (E), Openness to Experience (O), Agreeableness (A), and 
Conscientiousness (C). This five-factor model is measured with the revised 
NEO Personality Inventory (NEO PI-R). The theoretical formulation of 
personality traits has an hierarchical structure with broad descriptions of 
phenotypes that can be divided in different ways and on different levels in the 
hierarchy (Bouchard Jr & Loehlin, 2001). There are a substantial overlap 
between the three- and five dimensional models as well as others concepts in 
the field of personality (Bouchard Jr & Loehlin, 2001; Zuckerman & 
Cloninger, 1996). 
 
Whatever trait-model used, it is built on the assumption that one can predict 
how a person will act or react in a number of different situations. In order to 
say that a trait is valid, it must be stable over time. Personality is substantially 
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heritable. Behavior genetic studies suggest that 40 – 49% of individual 
differences in personality traits are due to genetics (Van Den Berg et al., 2014; 
Vukasović & Bratko, 2015).  Several studies have shown that personality is 
relatively stable (Edmonds, Goldberg, Hampson, & Barckley, 2013; Hampson 
& Goldberg, 2006), but it has also been suggested that personality changes 
gradually throughout life (Harris, Brett, Johnson, & Deary, 2016).  
 
The Swedish universities Scales of Personality (SSP) (Gustavsson et al., 2000) 
is a revised version of the Karolinska Scales of Personality (KSP) inventory 
(Schalling, 1970). The inventory was originally developed to explore the 
associations between personality traits and biological markers and as such 
predictive for health behavior and psychiatric illness. It is explicitly stated that 
the SSP does not intend to cover the full range of personality traits. The SSP 
was evaluated on a large sample of the Swedish population, which resulted in 
a three-dimensional model: Neuroticism, Aggressiveness, and Extraversion. 
The SSP traits have been shown to correlate with those measured with the 
NEO-PI-R, in particular the Neuroticism scales (Aluoja et al., 2009). The 
importance of evaluating the scales in various clinical samples was emphasized 
in the development of the SSP. Personality traits as measured with SSP has 
been studied in relation to different conditions such as schizophrenia, 
depressive and/or anxiety disorders, individuals undergoing in vitro 
fertilization, and post-partum depression (Fagerberg, Söderman, Gustavsson, 
Agartz, & Jönsson, 2016; Iliadis et al., 2015; Volgsten, Ekselius, Poromaa, & 
Svanberg, 2010). However, to our knowledge, personality traits has not been 
evaluated with SSP in BD. Personality traits measured with NEO Five-Factor 
Inventory during euthymic phases of BD have been suggested to be predictive 
of future mood course, suggesting that personality traits might be prognostic 
markers of the illness process (Barnett et al., 2011).  
 
In study V, we examined personality traits measured with SSP in 
individuals with bipolar disorder in comparison with healthy 
controls, and investigated the association between personality 
traits and illness course. 
 
The latest versions of Diagnostic and Statistical Manual for mental disorders 
(DSM) use a categorical approach of ten specific personality disorders to 
assess personality. Nevertheless, it has been shown that there is no clear 
boundary between normal and pathological personality. An alternative 
pathological personality trait model was suggested in Personality and 
Personality Disorder Assessment and Diagnoses for DSM-5 as (Skodol et al., 
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2011). Six broad, higher order personality traits were suggested: negative 
emotionality, detachment, antagonism, compulsivity and schizotypy. This re-
conceptualization also intended to identify personality-related problems and 
patient-specific personality trait profiles in addition to specific personality 
disorders. However, no change came about.     
Gray's conceptual framework 
Gray took his point of departure from Eysenck’s postulated differences 
between introverted and extraverted neurotics (Gray, 1986). He suggested that 
personality traits have a strong biological foundation and postulates two 
different systems; the Behavioural Activation System (BAS) and a Behavioural 
Inhibition System (BIS). BIS regulates avoidance behaviors and is activated to 
avoid punishment (punishment system). BAS on the other hand regulates 
approach behaviors and is activated to reach a goal, and is involved in the 
generation of anticipatory of positive affect (reward system). BAS and 
Extraversion have nearly the same psychometric construct. Extraversion is 
related to mood maintenance, which is different from mood repair predicted 
by Neuroticism, and may be a way for extraverts to extend arousal (Robinson, 
Watkins, & Harmon-Jones, 2013). For example, individuals with BD show 
rumination on positive affect. According to the BAS Hypersensitive Model of 
Bipolar Spectrum Disorder, individuals with higher sensitivity are at risk for 
BD and hypomanic/manic episodes by virtue of a hypomanic personality that 
interact with positive and negative life events, so called BAS-events (Urošević, 
Abramson, Harmon-Jones, & Alloy, 2008). Conversely, individuals high in 
BIS are at greater risk for episodes of depression (Alloy et al., 2008). 
Bipolar spectrum  
A bipolar spectrum concept has been proposed with a continuous distribution 
of depressive and hypomanic/manic symptoms and disorders from normal to 
pathological (Angst, 2007). Akiskal et al. (2006) propose a state-trait 
continuum and that it is possible to grade bipolar types and unipolar 
depression in terms of emotionality. Atypical depressive presentations and mood 
temperaments are part of that continuum (Ghaemi, 2013). Akiskal et al. (2006) 
showed that the most salient differences between bipolar I and II disorder are 
the levels of Neuroticism. Individuals with BD II and recovered unipolar 
depressed patients showed abnormally elevated scores in Neuroticism, 
whereas individuals with BD I scored near normal. However, in BD II, 
fluctuations between subsyndromal depressive and hypomanic symptoms 
accounted for high scores in Neuroticism, while dysthymic symptoms 
predicted outcome in unipolar patients. These differences between BD I and 
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BD II might explain why bipolar type II patients more often are diagnosed 
with personality disorder, even though Neuroticism might actually be 
characteristic for the BD II subtype.  
 
In study V of this thesis, we investigated differences between 
bipolar I and II in terms of personality traits.  
Neuroticism  
It is well known that high levels of Neuroticism is strongly associated with 
common mental disorders, e.g., anxiety, mood, and substance use disorders 
(Ormel et al., 2013). Neuroticism actually predicts a wide variety of outcomes 
such as mental and general health service use and quality of life (Lahey, 2009). 
Trait features associated with Neuroticism are for instance anxiety, anger 
hostility, depression, self-consciousness, impulsiveness, and vulnerability 
(Costa Jr & McCrae, 1992). Significant genetic associations have been found 
between Neuroticism and depressive symptoms, major depressive disorder, 
subjective well-being, and BD (Luciano et al., 2018). Personality factors may 
influence the kind of life-events individuals experience: Neuroticism 
influences stress vulnerability (Matthews et al., 2009), in particular when 
exposed to threat appraisals (Schneider, 2004). Individuals high in 
Neuroticism tend to use less problem-focused, and more emotion-focused 
and avoidance strategies.  
The p-factor  
Caspi et al. (2014) showed that one General Psychopathology Factor – the p 
factor – underlies core psychopathological processes, represented by an 
Internalizing (including anxious and depressive symptoms) and an 
Externalizing dimension (including aggressive, delinquent, and hyperactive-
impulsive symptoms). p is characterized by high Neuroticism and low 
Agreeableness and Conscientiousness. A general factor in psychopathology 
can be described analogously to g – the general cognitive ability. p summarizes 
an individuals’ tendency to develop any type of psychopathology. 
Consequently, higher scores on p are related to impairments in real-world-
functioning, worse developmental histories, and reduced cognitive 
functioning.  
The relationship between cognitive functioning and personality  
The degree to which personality and cognitive ability are linked are as yet 
undecided (Rammstedt, Danner, & Martin, 2016). Personality may alter styles 
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of cognition and learning (Matthews et al., 2009). There are some evidence 
that personality and intelligence are related throughout life (Harris et al., 2016). 
However, the cross-sectional correlations between intelligence tests and major 
personality traits is rather weak (Matthews et al., 2009; Schaie, Willis, & Caskie, 
2004). A positive correlation have been reported between Openness to 
experience and intelligence (Bartels et al., 2012; Chamorro-Premuzic & 
Furnham, 2008), whereas both Neuroticism and Conscientiousness have been 
found to be negatively correlated  (Furnham, Dissou, Sloan, & Chamorro-
Premuzic, 2007; Rammstedt et al., 2016). Eysenck proposed that persons high 
and low in trait anxiety show differences in cognitive functioning when 
processing threathening stimuli (Eysenck, MacLeod, & Mathews, 1987). In 
line with this, Neuroticism has been found to be associated with deficits in 
some aspects of attentional processing, perceptual ability, and working 
memory capacity (Eysenck et al., 1987; Modi, Kumar, Kumar, & Khushu, 
2015). Older people who score high in Neuroticism perform poorer on tests 
measuring cognitive function, and also show more rapid decline in cognitive 
function, largely independent of depressive disorders (Chapman et al., 2012). 
Besides, they are at greater risk for dementia. Other traits might also have 
prognostic value: higher Extraversion and lower Openness have been 
associated with worse cognitive functioning over time. On the other hand, 
people with high Conscientiousness had a less pronounced cognitive decline.  
 
In study VI of this thesis, we investigated the potential overlap 
between cognitive functioning and personality.  
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Aims 
The overarching aim of this thesis was to use traditional statistical methods 
along with multivariate projection methods to explore cognitive function and 
personality in bipolar disorder.  
 
The specific aims in each paper included in this thesis were: 
 
 a) to identify those neuropsychological tests that most reliably 
tell euthymic bipolar patients and healthy controls apart; b) to 
clarify the extent to which these cognitive impairments are 
clinically significant in a neuropsychological sense as opposed 
to merely statistically different from a healthy control group; c) 
to elucidate if individuals with bipolar disorder I and II are 
cognitively dissimilar; d) to elucidate if the degree of cognitive 
impairment is associated with psychosocial and clinical 
variables. 
 
 to investigate whether the correlation structure between 
various cognitive abilities differs between individuals with 
bipolar disorder and healthy controls. 
 
 to compare the neuropsychological profiles of adult BD 
patients with and without comorbid ADHD. 
 
 a) to elucidate if long-term changes in cognitive functioning in 
individuals with bipolar disorder differ from normal human 
cognitive aging, and b) to investigate if subsets of patients 
feature different cognitive trajectories. 
 
 a) to study personality traits in individuals with bipolar disorder 
type I and II in comparison with healthy controls; and b) to 
investigate the association between personality traits and illness 
course. 
 
 a) to explore whether the cognition/personality interface is 
altered in bipolar disorder; and b) to investigate if combining 
cognitive predictors with personality measures increase the 
prognostic power. 
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Methods 
The St. Göran bipolar project (SBP) is an interdisciplinary, prospective, 
naturalistic study of bipolar disorder. The aims of this project are to study the 
course and outcome of treatment in standard psychiatric health care, and to 
investigate the pathophysiology of bipolar disorder. Yet, the overarching goal 
is to reduce time spent ill and suffering for individuals with BD, and to 
improve everyday functioning and quality of life. To these ends, the ambition 
is to follow most study subjects for the length of their lifetime. Patients have 
been recruited and followed-up at two specialized out-patient clinics in 
Stockholm and Gothenburg. The papers included in this thesis are based on 
data collected in Stockholm. 
Recruitment process 
New and ongoing patients that met the inclusion criteria was offered the 
opportunity to be included in the study. The objectives, procedures, and a clear 
explanation of the risks and benefits of the study was presented orally and in 
writing prior to study inclusion. Healthy controls were contacted by mail with 
written information and informed orally over telephone and at the 
examination. The voluntary nature of research participation was clearly 
explained to patients and controls, as was their right to withdraw consent or 
to leave the study at any time. Patients were informed that the decision to 
accept or decline participation in the study would not affect their regular health 
care. All participants provided written consent. Copies of the signed consent 
form were given to all participants. Without this consent, no data was entered 
into the study database.   
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Figure 1 
The SBP flowchart below outlines key study events 
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Clinical assessments and diagnostic procedures at baseline 
Psychiatric interview 
Bipolar disorder diagnoses were established using the Swedish version of the 
Affective Disorder Evaluation (ADE), which is a semi-structured interview 
developed for the Systematic Treatment Enhancement Program for Bipolar 
Disorder (STEP-BD) (Sachs et al., 2003). The ADE is a systematic assessment 
of the patient’s current mental state, psychiatric history, and affective diagnosis 
according to DSM-IV criteria as per the Structured Clinical Interview for 
DSM-IV (SCID). Moreover, The M.I.N.I. International Neuropsychiatric 
Interview (M.I.N.I.) was used to screen for other psychiatric diagnoses than 
mood disorders (Sheehan et al., 1998). Clinical best estimate diagnoses were 
set based on all information available at admission by a consensus panel of 
experienced board with certified psychiatrists specialized in BD.  
 
The evaluation of ADHD was conducted independent from the baseline 
assessment by two board-certified psychiatrists. The examination was 
conducted when patients were clinically stable and rating-scales were if 
possible supplemented with parental interview (or other next to kin).  
Rating scales and questionnaires   
Rating scales and questionnaires were administered to obtain information 
about patients’ and healthy controls’ psychiatric symptoms, but also to 
describe past and present behavior, e.g., creativity, personality, sense of 
coherence, different areas of functioning. The following scales and 
questionnaires were included in study I-VI (Table 2).  
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Table 2 
Scales from SBP used in paper I-VI 
 
Rating scales and questionnaires and  
specific focus 
Scale  Focus  
Adult ADHD Self-Report Scale (ASRS)* Screens for adult ADHD 
Brown Attention-Deficit Disorder Scales 
(Brown-ADD)* 
Screens for executive cognitive functioning 
associated with ADHD in adults 
Ritvo Autism Asperger’s Diagnostic Scale 
(RAADS) 
Screens for symptom in Autistic Disorder and 
Asperger’s Disorder 
The Autism- Tics, AD/HD and other 
comorbidities inventory (A-TAC)* 
Screens for autism spectrum disorders, ADHD, 
tic disorders, developmental coordination 
disorders, learning disorders, and associated 
childhood mental disorders 
Sheehan Disability Scale (SDS) Assesses functional impairment in work/school, 
social life, and family life 
Autism Spectrum Quotient (AQ) Screen for high functioning autism spectrum 
disorders 
Alcohol Use Disorders Identification Test 
(AUDIT) 
Screens for alcohol-related problems 
Drug Use Disorders Identification Test 
(DUDIT) 
Screens for drug-related problems 
Young Mania Rating Scale (YMRS)  Assesses manic symptoms 
Montgomery-Åsberg Depression Rating Scale 
(MADRS ) 
Assesses depressive symptoms 
Clinical Global Impressions – Severity and 
Improvement Scales (CGI)  
Assesses severity of illness, improvement  
and treatment response 
Global Assessment of Functioning (GAF) Assesses how well a person function with 
 respect to activities of daily life 
Sheehan Disability Scale (SDS) Assesses patients’ subjective experiences of 
functional impairment 
Psychological general wellbeing (PGWB) Assesses anxiety, depressed mood, positive well-
being, self-control, general health 
Note. * used to establish childhood or adult ADHD in the SBP-cohort in Stockholm 
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Swedish universities Scales of Personality (SSP) 
This scale measure 91 items consisting of a statement with a four-point 
response format. All items are grouped into 13 scales (Table 3) that form 
different dimensions of personality such as Neuroticism, Aggressiveness, and 
Extraversion (disinhibition). The scale can be found in the Appendix. 
 
Table 3 
The SSP with corresponding personality traits and description of subjects 
with high scores of the constituent scales  
 
SSP and characteristics of subjects with high 
scores 
SSP and corresponding trait Characteristics of subjects with high scores   
Neuroticism: 
 
Lack of assertiveness Lacks ability to communicate effectively and to 
be self-assertive in different social situations   
Mistrust  No trust or confidence in others 
Somatic trait anxiety  Autonomic disturbances and feels  
restless and tense  
Psychic trait anxiety  Worrying and has low self-confidence   
Stress susceptibility Stress vulnerable  
Embitterment Unsatisfied and becomes easily jealous  
Aggressiveness:  
Social desirability  Adjusts easily socially to different situations and 
among others 
Physical trait aggression  Starts fights and hits back 
Verbal trait aggression  Engage in verbal arguments in an aggressive way 
Trait irritability  Irritable and impatient  
Extraversion (disinhibition):   
Detachment Lack of emotional connections with others 
Adventure seeking  Desire for activities involving sensations and risk  
Impulsiveness Impulsive, thoughtless, and indiscreet 
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Neuropsychological assessment  
The SBP cognitive battery has been set out as a fundamental part in reaching 
overall study aims. The tests were originally selected by psychologist Björn 
Hultman together with Mikael Landén with valued guidance from 
psychologist Håkan Nyman to secure an extensive and rigorous investigation 
of cognitive functioning in both patients and healthy controls. A licensed 
psychologist tested patients’ cognitive functioning over two sessions. The 
healthy controls were assessed by trained research associates, supervised by a 
licensed psychologist, at a single session. For patients, the cognitive testing 
session occasionally lag behind the clinical assessment at study entry due to 
limited number of psychologists carrying out cognitive testing. Table 4 shows 
test included in the SBP cognitive battery.  
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Table 4 
Tests included in the SBP cognitive battery 
 
Key tests of the SBP cognitive battery 
Test  Assessment activity  Measures 
Wechsler Adult 
Intelligence Scale  
Third Edition  
(WAIS-III): 
Includes verbal and non-verbal 
performance tests 
Measure of adult's  
intellectual ability 
Block Design The subject has to use blocks to 
construct replicas of patterns 
presented  
Visuospatial organization 
Matrix reasoning  Visual pattern completion and 
analogy problems 
Fluid intelligence 
Comprehension  Open-ended questions Common sense and judgment 
Information Open-ended questions General knowledge 
Similarities The subject has to explain what each 
pair of concepts has in common 
Verbal concept formation 
Vocabulary  Definitions of words Vocabulary 
Arithmetic Solve arithmetic problems Working memory 
Digit span Comprises digit span forward- and 
backward. The subject has to repeat 
sequence digits, first exactly as given 
and then backward. 
Immediate verbal recall 
(attention). And working 
memory 
Symbol Search  Series of symbols, each consisting  
of a target and a search group, from 
which the subject has to choose the 
appropriate box pending on the 
presence of target.  
Attention and processing 
speed 
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Test  Assessment activity  Measures 
Digit Symbol-Coding The subject is asked to fill in blank 
spaces according to a key with paired 
number and symbols. 
Attention and  
processing speed. 
Picture arrangement Drawing of cartoon pictures that 
have to be arranged in stories.  
Social cognition and sequential 
thinking. The ability to see 
relationships between events. 
Letter-Number Sequencing  The subject listens to a sequence of 
randomized numbers and letters 
(alternating) and is asked to repeat 
them in numerical and alphabetical 
order. 
Attention and  
working memory. 
Picture completion The subject has to identify important 
parts which are missing in 
incomplete pictures.  
Visual perception and 
organization and attention. 
Conners’ Continuous 
Performance Test II  
(CPT II) 
The subject is asked to execute a 
computerized test, in which stimuli 
(target letters and non-targets) are 
presented rapidly during 14 minutes. 
The subject has to respond in 
accordance to stipulated rules. 
Vigilance, inattentiveness,  
and impulsivity. 
 
Claeson-Dahl  
Verbal Learning  
and Retention Test 
A 10-word list task, which the subject 
is asked to learn through listening. 
The retention dimension involves 
remembering as many words as 
possible from the original list, and  
to present them in the right order. 
Eventually, the subject is asked  
to recognize the words from the 
original list among similar distractors. 
Verbal learning, episodic 
memory, and immediate  
and delayed recall.  
 
Rey Complex Figure Test 
and Recognition Trial 
(RCFT) 
A test of visuospatial constructional 
ability and visual memory. The 
subject is asked to copy a complex 
figure. Thereafter to draw the figure 
from memory after 3 and 30 min. 
The subject is also asked to recognize  
the components from the original 
illustration among similar distractors. 
 
Visuospatial constructional 
ability, and visual memory 
(immediate and delayed recall, 
and recognition). 
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Note. Freely after Lezak (2012) and the manual for Claeson-Dahl Verbal Learning and Retention Test 
Claeson & Nyman (1998). 
 
 
Test  Assessment activity  Measures 
Delis-Kaplan Executive 
Function System  
(D-KEFS): 
 
Key aspects of executive 
functions including mental 
flexibility, concept formation, 
problem solving, and 
inhibition. 
Color-Word Interference Test 
(CWIT) 
The subject has to read names of 
colors (e.g., red, blue, green) printed 
in dissonant colors. Thereafter, the 
subject is asked to switch between 
reading words and naming the colors 
of the words. 
The ability to inhibit automatic 
verbal responses, and cognitive 
flexibility. 
Trail Making Test (TMT)  The subject has to connect a 
sequence of 25 sequential numbers 
and/or letters as fast as possible. 
Thereafter the subject has to 
alternate between connecting 
numbers and letters in numerical and 
alphabetical order. 
The ability to inhibit automatic 
responses, and cognitive 
flexibility 
Design Fluency Test (DFT) The subject has to draw as many 
different designs as possible in 60 
seconds by connecting a set of 
printed dots. 
The capacity of initiating 
problem-solving behavior, 
cognitive flexibility, and 
inhibition of automatic 
responses. 
Verbal Fluency Test (VFT) The subject is asked to say as many 
words as possible from a given 
category (phonemic and semantic) in 
60 seconds. Thereafter, to alternate 
between words from two semantic 
categories.  
Language skills and verbal 
processing ability, as well as 
problem solving and 
inhibition. 
Tower Test The subject has to move discs from a 
starting position to a target position, 
in accordance to stipulated rules. 
Planning and aspects of 
problem solving, e.g., the 
ability to inhibit perseverative 
and impulsive responses. 
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Other assessments   
The SBP investigations also included a magnetic resonance imaging brain scan 
at baseline and follow-up. Cerebrospinal fluid was also collected through 
lumbar puncture to shed light on the pathophysiology of BD. None of these 
measures are, however, used in this thesis. 
Other variables 
A wealth of information was collected at study entry on, e.g., heritability, 
somatic diagnoses, years of completed education, occupational status, age at 
onset, number of affective episodes, medication status, and lifetime history of 
psychosis et cetera.  
Inclusion and exclusion criteria 
Inclusion criteria for patients: 
i) Current age  16 years of age;  
ii) Meets DSM-IV Criteria for Bipolar I disorder, Bipolar II disorder, 
Bipolar NOS, Cyclothymia, or Schizoaffective Manic/Bipolar type;  
iii) Completed baseline evaluation with the ADE (the complete set of 
investigations varies across study subjects as not everybody 
volunteered for all examinations);  
iv) Oral and written informed consent to participate in the study.  
Exclusion criteria for patients:  
i) Unwilling or unable to comply with study requirements, e.g., complete 
forms, or attend planned evaluations;  
ii) Not competent to give informed consent in the opinion of the 
examiner. 
Of note, specific inclusion criteria were established for patients in paper I-VI 
depending on study objectives. However, in all papers, only bipolar I and II 
disorder patients were included. Euthymia, when used as an inclusion 
criterion, was defined as stable mood according to treating physician together 
with scores below 14 on the MADRS and YMRS rating scales. 
Inclusion criteria for healthy controls:  
i) signed informed consent 
ii) completed questionnaires, psychiatric interview, blood tests and 
screening neuropsychological tests 
Exclusion criteria for healthy controls:  
i) any current psychiatric disorder or current treatment with any 
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psychotropic drug 
ii) a history of conduct disorder or ADHD, bipolar disorder, 
schizophrenia, or other psychiatric disorders other than past minor 
depressive episodes, previous isolated episodes of panic disorder or 
eating disorders, which had remitted spontaneously or with short term 
psychotherapy.  
iii) a first degree relative with bipolar disorder or schizophrenia 
iv) overconsumption of alcohol as revealed by carbohydrate deficient 
transferrin (CDT) in blood test or AUDIT responses indicating large 
consumption (>8 standard drinks per time more than 2 times per 
week), and/or amnesia and/or loss of control more than once per 
month 
v) any illicit drug use 
vi) pregnancy, untreated endocrine disorders, other medical illness, 
dementia or neurological disorder other than mild migraines 
vii) subjects presenting conditions that precluded magnetic resonance 
imaging of the brain (e.g., metal implants, shrapnel, and certain heart 
operations). This exclusion criterion was due to a planned brain 
magnetic resonance imaging for another part of the St. Göran bipolar 
project. 
Sample  
Table 5 
The study sample included in study I-VI from the Stockholm SBP-cohort 
 Study sample from the SBP Stockholm cohort 
Subjects  N 
Age at 
onset 
M 
Age at 
inclusion  
M 
Women 
(%) 
Total no. of 
mood 
episodes 
 M 
WAIS-III 
FSIQ 
M 
WAIS-III 
Vocabulary  
M 
At least  
two years  
of tertiary 
education  
(%) 
BD I 161 19 36  58 15 105 11 50 
BD II 99 19 39 65 32 109 12 66 
Other 33 20 38 60 9 105 11 58 
HC 115 
 
38 55 
 
114 11 62 
Note. Other = meets DSM-IV Criteria for Bipolar NOS, Cyclothymia, or Schizoaffective Manic/Bipolar type, FSIQ = 
Full Scale Intelligence Quotient 
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Statistical analyses 
In study I, II, and VI, we used multivariate projection methods to examine 
similarities and differences between individuals with BD and healthy controls.  
Principal component analysis (PCA) forms the basis of multivariate data 
analysis. A PCA reduces data dimensions and summarizes systematic variation 
in a model by aggregating variables in ‘components’ or ‘latent variables’ that 
describe the correlations structure (Eriksson, Byrne, Johansson, Trygg, & 
Vikström, 2013). A PCA-model shows both how observations are related and 
how variables are related. By creating a PCA-model, it is possible do detect 
variables that contribute similar information to the model, as well as variables 
that contribute with unique information to an observation.  
 
To understand how PCA works, “consider a matrix (X) with N observations 
and K variables. For this matrix we construct a variable space with as many 
dimensions as there are variables. Each variable represents one co-ordinate 
axis” (Eriksson et al., 2013, p. 37)“. The first principal component (PC1) 
represents the maximum variance direction in the data (X). The PC1 is a line 
to which observations can be projected. Thus, each observation (each study 
subject in our case) acquires a score on PC1. The second principal component 
(PC2) reflects the second largest source of variation in data, and is orthogonal 
to the PC1. When two principal components have been derived they form a 
two-dimensional plane that can be visualized in a coordinate system, which 
can be seen as a window into a multidimensional space. The principal 
component loadings give information on variables of importance. The PCA 
model can be evaluated by the goodness of fit parameters R2X (the explained 
variation) and Q2X (the predicted variation). The difference between these two 
parameters should not exceed 0.2-0.3. The actual values of R2X and Q2X are 
highly application dependent, and the model can be useful even if Q2X is less 
than 0.5 as it separates useful information (PC) from noise. 
 
The Projection to Latent Structures by means of partial least squares (PLS) is 
a regression extension of a PCA that is commonly used for prediction. In a 
PLS, the variables are divided into two blocks called X (predictor variables) 
and Y (response variables) A PLS connects the information from these two 
blocks to develop a relationship between them. PLS does not give information 
about how much of the variability in X is predictive.  
 
To draw conclusions about similarities and differences among observations, a 
Coomans' plot can be constructed. Model-membership of an observation can 
be decided by plotting observations' model distances (DModXs') against each 
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other in a scatter plot.  If a Coomans' plot shows a large overlap between two 
groups, the conclusion is that the groups are similar. 
 
Orthogonal partial least squares discriminant analyses (OPLS-DA) operates 
by dividing the systematic variation in a dataset into two parts: one that is 
predictive of class membership, and one that is uncorrelated, orthogonal, to 
the class membership. Hence, whereas the PCA is an unsupervised analysis that 
maximizes the variance of each component regardless of class membership 
(i.e., the model is not given any a priori information on phenotype), the OPLS-
DA is a supervised analysis that aims to separate groups and is built to maximize 
the relationship between each component and the class membership (e.g., 
patients and controls). 
 
For these multivariate analyses, we used the SIMCA software: SIMCA-P 13.0, 
SIMCA 14.0, and SIMCA 15.0 (Eriksson et al., 2013). 
 
The following additional statistical methods were applied in study III, IV, and 
V: In study III, differences in cognitive functioning between individuals with 
BD with and without comorbid ADHD were tested with t-tests. In study IV, 
the main analysis tested if the change in cognitive function over time differed 
between patients and controls. To this end, we conducted repeated measures 
Analysis of variance (ANOVA) with group (patients vs. healthy controls) as a 
Between-Subject Factor. Binary logistic regression analyses were used to 
estimate strength of associations which were expressed as odds ratios. In study 
V, we conducted multivariate analysis of variance with a covariate 
(MANCOVA) to investigate overall group differences in SSP personality 
traits. Binary logistic regression analyses were used to estimate strength of 
associations, which are expressed as odds ratios with 95% confidence 
intervals. Statistical significance was set at a two-sided P-value of < 0.05, when 
not corrected for multiple testing (study VI). For the above analyses, we used 
IBM SPSS Statistics. 
Approvals from the ethics committee  
All studies in this thesis were approved by the Ethics committee of the 
Karolinska Institutet, Stockholm, Sweden (Dnr: 2005/554-31/3, 2009/1221-
32) 
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Results 
Results of study I  
This study examined the clinical relevance of cognitive impairments in BD. 
We also examined if cognitive abilities differ between BD subtypes and HC. 
Results showed that individuals with BD I and II, and HC were partially 
separated based on their performance on a comprehensive battery of cognitive 
tests (Figure 2).  
 
Figure 2 
The OPLS-DA score plot shows a partial separation between patients with 
bipolar I disorder (top panel), bipolar II disorder (middle panel), and healthy 
controls (lower panel). Each participant’s score is represented by a circle. The 
scores corresponds to t[1] values on the component predictive of diagnostic 
group. 
 
 
 
Both BD type I and type II were associated with cognitive impairment that 
for a sizeable minority is significant in a clinical neuropsychological sense. At 
the 11th percentile threshold, the prevalence for clinically significant 
impairment ranged from 11 to 48% across different cognitive tests, e.g., 40 
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% on TMT 4 and block design. (Results in Study I show no impairment 
prevalence rates if no group differences between patients and healthy controls 
were found.)  
 
The combination of cognitive tests that most reliably detected cognitive 
impairment in BD were tests from D-kefs (TMT, VF, CWIT) and Symbol 
Search from WAIS-III. We found no associations between cognitive 
functioning and clinical and psychosocial outcomes. 
 
Note. Figure and results from Sparding et al., 2015. PLoS One, 10(1).  
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Results of study II  
This study investigated whether the correlation structure between cognitive 
abilities differs between individuals with bipolar disorder and healthy controls. 
Given the dissimilarities of the PCA models of cognition in BD and HC, we 
constructed a Coomans’plot (Figure 3), in which the model distances 
(DModX’s) for BD and HC were plotted against each other. The figure shows 
that approximately 30% of BD patients do not fit to the cognitive model built 
for healthy controls. We call this group the ‘cognitive subgroup’ of BD 
patients. The correlation structure of the constituent neuropsychological 
variables thus differed between this cognitive subgroup of BD and the 
majority of BD individuals, where the main difference concerned learning and 
memory aspects of Digit Symbol Coding, Claeson-Dahl, and the Rey Complex 
Figure Test. Moreover, there was also an increase in the number of rule 
violations in the Tower test in the cognitive subtype group.  
 
The cognitive subtype group was similar to the rest of the individuals with BD 
with regard to demographic and clinical variables. For example, the two groups 
had similar scores on the MADRS and YMRS inventories, and did not differ 
by sub-diagnosis (type I/type II). 
 
Figure 3 
The Coomans’ plot of cognitive performance in patients with bipolar disorder 
and healthy controls. 
 
 
Note. The co-ordinates are the model distances (DModX values) to the models built for patients (y-axis) 
and healthy controls (x-axis). Patients are represented by black boxes and healthy controls by white triangles. 
Subjects that fit both models are found in the lower-left hand region of the plot. The cognitive subgroup 
of bipolar disorder patients (~30%) that did not conform to the model for healthy controls is found in the 
in the upper and lower right-hand quadrants. Figure and results from Sparding et al., 2017. Cognitive 
Neuropsychiatry, 22(5), 407-421. 
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Results of study III 
This study compared the neuropsychological profiles of adult BD patients 
with and without comorbid ADHD. The groups did not differ significantly in 
their performance on nine out of ten cognitive tests (Table 6). Moreover, the 
groups did not differ with respect to sex, age, type of BD, or global IQ (as 
measured by WAIS-III).  
 
However, the BD+ADHD group was significantly younger at age of first 
psychiatric symptom, as well as at age of first affective episode. The number 
of mixed episodes was significantly higher for the BD+ADHD group, 
whereas no group differences were found regarding number of manic, 
hypomanic, or depressive episodes. Lithium treatment was significantly more 
common in BD patients without ADHD, while other mood stabilizers where 
more common in the BD+ADHD group. No differences were found 
regarding level of education, employment status, or number of sick-leave days 
the previous year. 
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Table 6 
Comparison of neuropsychological test performance of the pure bipolar 
disorder group and the bipolar disorder + ADHD group. 
 Comparison of test profiles of individuals with and without 
comorbid ADHD 
Cognitive test Pure BD 
 
BD + 
ADHD 
   
 
M(SD) M(SD) t p 
Cohen’s 
d 
WAIS-III: Verbal 
Comprehension Index 
109.8(13) 112.5(10.6) -.98 .33 -.23 
WAIS-III: Perceptual 
Organization Index 
109.4(16.5) 106.1(14.4) .91 .37 .21 
WAIS-III: Working 
Memory Index 
102.2(14.9) 95.4(11) 2.15 .03 .52 
WAIS-III: Processing Speed 
Index 
99.1(15.8) 95.9(10.4) 1.12 .27 .24 
CPT2 Omission errors** 53.5 15.8) 53.9(16.7) -.10 .92 -.02 
CPT2 Comission errors** 54.2(9.9) 54.4(10.1) -.05 .96 -.02 
ColorWord 4 (Inh/Swi) 9.9(3) 9.5(3.1) .66 .51 .13 
Tower Test Total 11.4(3.3) 10.4(3.7) 1.17 .25 .29 
RCFT: Immediate recall  43.9 (14) 41.6(16) .70 .49 .15 
Claeson Dahl verbal 
learning 
46(12.9) 48.8(9.3) -1.15 .25 -.25 
Note. Data were missing for some patients and therefore the N varies. Pure BD: n=56-64, 
BD + ADHD: n=23-31. ** Higher score indicates better performance on all tests except 
CPT, where lower score indicates better performance. 
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Results of study IV 
This study examined if long-term changes in cognitive functioning in 
individuals with BD differ from normal aging. By and large, the change in 
cognitive functioning between baseline and six-year follow-up did not differ 
significantly between cases and healthy controls (Table 7). Moreover, the 
diagnostic subgroups BD I and BD II did not differ regarding change in 
cognition over the study period. The cognitive subgroup of individuals with 
BD identified in study II remained stable and did not change more or less than 
BD patients with normal performance at baseline, except for one test: the 
WAIS-III subtest ‘block design’, where the BD cognitive subtype slightly 
worsened while the rest of the individuals with BD slightly improved 
(p=0.045). Finally, patients who had at least one manic or mixed episode did 
not show greater cognitive decline than those with no manic or mixed episode.  
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Table 7  
Individuals with bipolar disorder (BD) in comparison with healthy controls with respect 
to the change in performance on cognitive tests between baseline (T1) and follow-up 
(T2). Results are presented as mean raw scores with standard deviation (SD) and 
statistics for the group x time interaction.  
 Long-term trajectory of cognition in bipolar disorder and healthy controls 
 Bipolar disorder Healthy controls  Group x time 
Group x 
timea 
Cognitive test 
T1 
M(SD) 
T2 
M(SD) 
N 
T1 
M(SD) 
T2 
M(SD) 
N F p p2 p 
CWIT 3: Inhibition 53(13) 57(25) 61 47(9) 47(9) 57 3.63 0.059 0.030 0.045 
CWIT 4: 
Inhibition/Switching 
61(15) 62(21) 61 55(12) 55(17) 56 0.13 0.91 0.00 0.81 
VFT: CF 49(13) 50(11) 66 54(9) 55(11) 55 0.34 0.56 0.003 0.83 
VFT: Switching 15(3) 16(4) 65 17(3) 16(2) 55 4.64 0.033 0.038 0.08 
TMT 4: Switching 78(29) 78(35) 56 62(17) 65(27) 55 0.37 0.56 0.003 0.69 
RCFT: time to copy  198(10
3) 
190(97) 66 152(59) 156(71) 55 0.63 0.43 0.005 0.40 
RCFT: IR  19(7) 18(8) 67 22(6) 22(6) 57 1.43 0.23 0.012 0.17 
WAIS-III: 
Similarities 
23(6) 25(6) 70 27(4) 27(5) 58 7.35 0.008 0.055 0.02 
WAIS-III:  
Block design 
46(10) 47(14) 71 51(10) 52(10) 59 0.91 0.84 0.000 0.99 
WAIS-III: DSST  73(18) 68(19) 71 78(16) 73(17) 58 0.004 0.95 0.000 0.97 
WAIS-III: SS 33(9) 33(10) 71 36(8) 38(8) 59 2.27 0.13 0.002 0.15 
WAIS-III - DSC IL: 
Pairing 
13(5) 12(5) 54 15(4) 14(5) 41 0.57 0.45 0.006 0.62 
CD VL 87(71) 77(62) 34 64(56) 49(48) 50 0.91 0.66 0.002 0.66 
CPT-II: Omissions  5(15) 5(9) 45 2(3) 2(3) 42 0.025 0.88 0.000 0.79 
Note. a adjusted for age at baseline, p2=partial eta squared=effect size, abbreviations cognitive tests: CWIT=Color Word 
Interference Test, VFT=Verbal Fluency Test, CF=Category Fluency, TMT=Trail Making Test, RCFT=Rey Complex 
Figure test, IR=Immediate Recall, WAIS-III=Wechsler Adult Intelligence Scale III, DSST=Digit symbol substitution test, 
SS=Symbol Search, DSC IL=Digit-Symbol-Coding-Incidental Learning, CD VLT=Claeson-Dahl Verbal Learning (and 
Retention) Test, CPT-II: Omissions= Conners' Continuous Performance Test II Omissions. 
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Results of study V 
In this study, we examined if personality traits differ between individuals with 
BD and healthy controls. We also tested the association between personality 
traits and illness course. Individuals with BD I and II were similar with regard 
to their personality profile. Both groups featured high scores on all personality 
traits (except social desirability) as measured with the SSP: Neuroticism, 
Aggressiveness, and Extraversion (disinhibition). Both types of BD showed 
significantly higher scores than HC (Figure 4).  
 
Yet, the personality scores did not have any prognostic value on illness course 
after controlling for concurrent depressive symptoms.   
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Figure 4 
Mean T-scores with 95% CI on SSP-derived Neuroticism-, Aggressiveness-, 
and Disinbition related subscales in patients with bipolar disorder (BD) I and 
II, and in healthy controls (HC). The ticked line shows the normative mean 
for a large Swedish sample (T-score = 50). 
  
 
Note: Figure and results from Sparding et al. (2017). BMC Psychiatry, 17(1), 159 
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Results of study VI  
In this study, we examined if the cognition/personality interface is altered in 
BD and if so, whether such difference would increase the understanding of 
the illness course. The correlational structure did indeed differ between HC 
and BD in that the performance on a wide range of cognitive tests and 
personality scales measured with SSP was not as tightly coupled or dominated 
by a single personality trait in HC as it was in BD (Figure 5). Neuroticism was 
more closely related to cognitive performance in individuals with BD than in 
HC. Somatic trait anxiety, Psychic trait anxiety, Stress susceptibility had the 
strongest bearing on cognitive tests measuring processing speed, inhibition, 
and cognitive flexibility.  
 
Combining cognition and personality had limited predictive power on 
functional outcomes over a 6-year period. Yet, PCA-models for personality, 
cognition, and the combination of cognition and personality did predict family 
/ home functioning at the six-year follow-up.
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Figure 5  
The column plot shows how cognitive tests and personality scales vary in 
relation to each other, which ones provide similar information, which ones are 
negatively correlated, or not related to each other, and which ones are not well 
explained by the model (p1 close to 0). Mean and standard deviation (SD) are 
displayed as scale score, and T-score. 
Note. Loadings (i.e., weighted averages of the variables) express the dominating correlation structure in the 
model. Hence, p1 show how the X-variables correlate, i.e., relate to each other in PC1. And the statistical 
significance of each variable is indicated with 95% confidence interval.  
 
  
Patients with BD   
Cognitive tests and SSP personality scales   Mean(SD)
TMT Number Letter Switching 9(3)
Symbol Search 10 (3)
Digit Symbol Coding 10(3)
TMT Letter Sequencing 10(3)
TMT Number Sequencing 9(4)
TMT Letter Number Sequencing 10(3)
Arithmetic 11(3)
VFT Letter Category 13(4)
VFT Letter Fluency 13(4)
CW Inhibition Switching 10(3)
Matrix Reasoning   13(3)
Block Design   12(3)
RCFT 30min Delayed Recall 44(14)
Picture Arrangement   10(3)
Information   13(2)
RCFT 3min Immediate Recall 44(14)
CW Color Naming 9(3)
CW Inhibition   10(3)
CW Word Reading   10(3)
DFT Switching 11(3)
VFT Category Switching Correct Responses   13(3)
Vocabulary 12(2)
TMT Visual Scanning   11(2)
VFT Category Total Switching Accuracy   12(3)
Similarities 11(3)
Digit Span   10(3)
DFT Total Correct 12(3)
Tower Total Achivement Score   11(3)
Picture Completion 10(3)
DFT Empty Dots Only 11(3)
TMT Motor Speed   12(2)
CD Total Achivement 47(12)
RCFT Recognition Trial  45(13)
CPT-II Hit RT   46(13)
CD Retention   46(12)
CPT-II Commissions   54(10)
Social desirability 47(10)
Adventure seeking 52(10)
CPT-II Omissions 60(46)
Verbal Trait aggression   51(9)
Detachment 48(11)
Impulsiveness 55(11)
Trait irritability 54(12)
Physical trait aggression   46(10)
Lack of assertiveness 49(10)
Embitterment 54(11)
Mistrust 50(13)
Stress susceptibility 56(14)
Psychic trait anxiety 46(10)
Somatic trait anxiety 53(11)
p1
p1Healthy control subjects
Cognitive tests and SSP personality scales  Mean(SD)
CW Inhibition 12(2)
DigitSymbol Coding 11(3)
CW Inhibition Switching 11(3)
CW Color Naming 10(2)
Vocabulary 11(2)
TMT Letter Number Sequencing 11(3)
Similarities 12(4)
VFT Letter Fluency 14(3)
VFT Letter Category 16(3)
Information   13(2)
TMT Letter Sequencing 11(3)
DFT Switching 13(3)
Symbol Search 12(3)
CW Word Reading   10(3)
DFT Total Correct 12(3)
CD retention 49(10)
RCFT 3min Immediate Recall 49(11)
CD Total Achivement 49(10)
RCFT Recognition Trial   51(10)
TMT Number Letter Switching 12(2)
VFT Category Switching Correct Responses 14(3)
TMT Number Sequencing 11(3)
RCFT 30min Delayed Recall 48(11)
Digit Span   11(3)
DFT Empty Dots Only 12(2)
TMT Visual Scanning   11(2)
Block Design   13(3)
Matrix Reasoning   14(2)
Picture Completion 12(3)
VFT Category Switching Total Switching Accuracy 13(3)
Arithmetic 12(2)
TMT Motor Speed   12(2)
Picture Arrangement   11(3)
CPT-II Hit RT   43(10)
Social desirability 53(11)
CPT-II Omissions 49(12)
CPT-II Commissions   51(9)
Tower Total Achivement Score   12(3)
Lack of assertiveness 48(8)
Detachment 45 (9)
Stress susceptibility 43(9)
Verbal Trait asggression 45(10)
Trait irritability 45(10)
Psychic trait anxiety 42(8)
Physical trait aggression   43(8)
Somatic trait anxiety 44(7)
Adventure seeking 49(8)
Mistrust 41(8)
Impulsiveness 46(9)
Embitterment 43(8)
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Discussion 
It has been well established that cognitive functioning is impaired in 
individuals with BD relative to HC (Arts et al., 2008; Bora et al., 2009; Mann‐
Wrobel, Carreno, & Dickinson, 2011; Robinson et al., 2006). However, there 
is no conclusive cognitive profile characterizing BD. The best way to describe 
the current state of knowledge is cognitive heterogeneity. 
 
The overwhelming majority of studies has focused on the magnitude of mean 
group differences on different cognitive tests. It is, however, possible to 
establish differences with large effect sizes between groups despite that the 
groups are more similar than different, with leads to exaggerated differences 
(Hanel, Maio, & Manstead, 2018). We exemplified this in the Introduction by 
comparing the BD groups from Stockholm and Gothenburg. Even though 
both groups were examined with the same study protocol from SBP, we 
obtained group mean differences with moderate effect sizes. With the 
approach used in a majority of studies in this field, one might allege that BD 
patients in Gothenburg are cognitively impaired in comparison with BD 
patients in Stockholm, even though this is likely to be explained by case-mix 
differences. 
Prevalence of cognitive impairments 
The majority of studies do not report the prevalence of cognitive impairments 
in BD, which hampers comparisons across studies. Study I was included in a 
review by Cullen and colleagues (2016), which were first to systematically 
review the prevalence of cognitive impairment in euthymic BD. In study I, we 
defined impairment threshold as <1.25 S.D. below the healthy control mean. 
This 11th percentile impairment threshold revealed prevalence ranges between 
11-48% across different cognitive tests. Surprisingly, the review by Cullen et 
al., demonstrated a wide variation in cognitive functioning in BD. At the 5th 
percentile impairment threshold, prevalence ranges were 5-58% for executive 
function, 10-52% for attention/working memory, 23-44% for speed/reaction 
time, 8-42% for verbal memory, and 12-33% for visual memory.  
There is no consensus on the impairment threshold. A recent study by Roux 
et al. (2019) was the first to validate criteria in BD that previously had been 
used to assess cognitive impairments in severe and persistent mental disorders.  
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The following five criteria were validated:  
i) Individual Profile Rating (IPR): at least two domains impaired 
(domain impairment definition: mean domain score <2 S.D. 
below the normative mean or <2 S.D. below any other cognitive 
domain), or one domain <3 S.D. below the normative mean. 
ii) Clinically Significant Cognitive Impairment (CSCI): at least two 
domains ⩽1 S.D. below the normative mean. 
iii) Global Deficit Score (GDS): a mean deficit score  0.5 (the 
deficit score was computed from the mean of the T scores of all 
variables).  
iv) Martino et al., Soft Criteria (MSC): at least one measure of one 
cognitive domain <1.5 S.D. below the normative mean. 
v) Martino et al., Hard Criteria (MHC): at least two measures of two 
different cognitive domains <2 S.D. below the normative mean. 
Three out of five criteria listed above use average scores for specific domains. 
We argue that performance variance seen in low-level cognitive abilities are 
not considered when calculating averages and that some valuable information 
is lost when doing so. Reporting domains can also make comparisons difficult 
because how domains are defined may differ among studies. The results are 
extremely criteria-dependent, e.g., the prevalence of cognitive impairment was 
4% with IPR, 17.4% with CSCI, 12.4% with GDS, 66.8% with MSC, and 
16.4% with MHC. Roux et al. (2019) concluded that only CSCI had 
satisfactory psychometric properties. Thus, only 12.4% of participants with 
euthymic BD had a clinically relevant cognitive impairment. They argue that 
previous studies in the field may have overestimated the prevalence of 
cognitive impairments in bipolar disorder. In the case of study I, the 
impairment threshold can be considered liberal compared with the validated 
criteria by Roux (2019).  
It is important to emphasize that if performance on cognitive test in 
individuals with BD would have been evaluated against norms, results would 
not have been significant: Patients perform in line with expected average 
results on the majority of test measures. The group differences between 
individuals with BD and HC found in study I occur largely because HC perform 
above or much above average on the majority of cognitive tests. Of note, in 
Sweden approximately 40 per cent of the adult population have at least two 
years of tertiary education (Statistics Sweden, www.scb.se). Among patients 
from the SBP Stockholm cohort, 50-64 percent had the corresponding 
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education. It has been suggested that many studies have sampling bias 
favouring cognitively impaired patients (Roux et al., 2019), which thus does 
not seem to be the case in study I-VI. Most patients at the out-patient clinic in 
Stockholm that were invited to SBP volunteered to participate and we had few 
exclusion criteria meaning that patients with co-occurring conditions are 
included in the SBP-cohort and thus in study I-VI. 
In the end, one cannot ignore the fact that there are a number of contextual 
factors, e.g., premorbid cognitive functioning and subjective decline that 
determine whether a patient can be considered suffering from cognitive 
impairments or not. 
Subgroups 
As was outlined above, it is possible that overall group differences in cognition 
are driven by one or more subgroups. Unlike the classical approaches in the 
field, we examined in study I and II whether the correlation structure between 
various cognitive abilities differs between individuals with bipolar disorder and 
healthy controls. To be able to handle about 50 different measures of cognitive 
functioning one can use multivariate data analysis. This makes it possible i) to 
examine measures that are highly correlated, ii) to look at all the measures 
together without losing any test specific information, iii) to discover 
underlying trends, so called “latent variables”, iv) to discriminate between 
groups, v) to avoid problems with mass significance, and vi) to identify 
similarities between groups. We argue that this statistical approach better 
reflects network alterations in brain regions underlying general cognitive 
performance demonstrated in psychiatric disorders (Sha, Wager, Mechelli, & 
He, 2019). We found that the majority of patients (70%) has the same 
correlation pattern among low-level cognitive abilities as healthy controls. 
Patients that deviated from the correlation structure seen in healthy controls 
formed a distinct subtype as their cognitive profile differed from the rest of 
the individuals with BD. The cognitive subtype group was additionally 
impaired in tests measuring different aspect of verbal and visual memory. This 
is interesting as we in study I showed that the combination of tests that most 
reliably detected cognitive impairment in bipolar disorder were measures of 
executive functioning/cognitive flexibility, shifting, inhibiting, and processing 
speed. 
 
We and others (Burdick et al., 2014; Lee et al., 2017) have identified one or 
more cognitive subgroups among bipolar disorder patients. Given that the 
nature of cognitive impairments in this subgroup is as yet not fully understood, 
  
 
65 
we suggest broad cognitive screening in BD rather than focusing on a specific 
cognitive domain. 
 
Despite the heterogeneity in cognitive profiles and presentations, it is known 
that cognitive impairment affects patients across the BD spectrum. However, 
few studies have investigated cognitive impairments in individuals with BD II 
compared with BD I (Solé et al., 2011). In the reanalysis carried out by Bourne 
(2013) on 31 data sets investigating cognitive performance in individuals with 
BD, only 12 percent out of 1276 patients had a bipolar II diagnosis. In study I, 
we suggested that there is a considerable overlap in cognitive performance in 
individuals with bipolar I and II disorders. This result is in line with a previous 
study from our research group that compared a part of the cognitive test 
battery in the same cohort of patients (Pålsson et al., 2013). By contrast, 
however, a recent meta-analysis that examined cognitive performance among 
subtypes of bipolar disorder suggested that individuals with BD I have more 
prominent impairments. Nevertheless, they concluded that different subtypes 
of the disorder do not explain the cognitive heterogeneity seen in the field 
(Bora, 2018). At present, we cannot exclude that individuals with BD II are as 
cognitively impaired as individuals with BD I.  
ADHD 
Determining the characteristics of cognitive impairments in a certain disorder 
is complicated by the possible co-occurrence with other psychiatric 
conditions. For example, the majority of studies (Bourne et al., 2013; Paul 
Roux et al., 2019) do not screen for ADHD despite that it frequently co-occurs 
with bipolar disorder (Rydén et al., 2009). In study III, we hypothesized that 
the prevalence of ADHD among individuals with BD might explain some of 
the cognitive impairments associated with BD. But our main finding was that 
the pure BD group did not differ from the BD + ADHD group. A study 
published in parallel with our work draws the same conclusion; it reported that 
individuals with BD and ADHD showed the same cognitive performance as 
those seen in individuals with BD alone (Torres et al., 2017). This is 
particularly interesting since executive dysfunction is thought to be a cardinal 
symptom of ADHD. Thus, ADHD is seen as a disorder accompanied by 
pronounced cognitive impairments that by definition are related to impaired 
everyday functioning. However, executive dysfunction is not a universal 
finding in ADHD but might occur only in a subgroup (Nigg, Willcutt, Doyle, 
& Sonuga-Barke, 2005). Bipolar disorder on the other hand has been 
suggested to qualify as a dysexecutive syndrome (Thompson et al., 2009), but 
it is not considered a hallmark of the disorder.  
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A clinical problem that has been identified by researchers is that tests of 
executive functioning lack ecological validity when judged against ratings of 
executive functions in daily life, or direct observation in natural settings 
(Barkley & Murphy, 2010). It is therefore possible that individuals with BD 
suffer from executive dysfunction that affect everyday life to a greater extent 
than what can be detected with cognitive testing. This highlights the 
importance of supplementing cognitive testing with rating scales and 
questionnaires to capture executive dysfunction, preferably with self-ratings 
together with evaluations of next of kin.  
Cognitive functioning, everyday life, and illness course  
The research field of psychometric cognitive testing of individuals with BD 
rests on the assumption that it provides meaningful information not only 
pertaining to everyday life, social relations and work, but also to future illness 
course. 
Processing speed performance has been shown to be the sole predictor of 
social and global functioning (Burdick, Goldberg, & Harrow, 2010). Also, 
verbal learning and memory have been shown to be more strongly related to 
scores on GAF than clinical symptoms. Cognitive performance has also been 
linked to poor occupational functioning (Bonnín et al., 2014; Gilbert & 
Marwaha, 2013; Mur et al., 2009; Ryan et al., 2013). In our research group, we 
have found that executive functioning is a more powerful predictor of 
occupational status in BD than IQ and clinical factors, e.g., illness severity 
(Drakopoulos, manuscript in preparation). However, in study VI, baseline 
cognitive performance only predicted functioning in family life and home 
responsibilities among the functional and illness course outcomes at the six-
year follow-up.  
Impaired cognitive functioning in bipolar disorder is most likely multifactorial. 
More severe or longstanding illness has been associated with greater cognitive 
impairment (Cullen et al., 2016). Moreover, Bourne et al., 2013 suggested that 
some of the cognitive heterogeneity may be influenced by drug effects (Bourne 
et al., 2013). Several studies have investigated the association between 
cognitive functioning and drugs with mixed findings (Cullen et al., 2016). To 
date, the strongest evidence of association has been found with antipsychotic 
medication and impaired cognitive functioning (Bourne et al., 2013; Cullen et 
al., 2016; Paul Roux et al., 2019). We, however, did not detect any association 
between clinical and functional outcomes and cognitive functioning in study I. 
Neither did we find any significant differences between the cognitive subgroup 
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and the majority of BD patients in study II with regard to clinical or functional 
variables.  
 
However, our findings of an absence of an association between cognitive 
functioning and clinical variables and functional outcomes should be treated 
with caution. First, some of the prospective longitudinal data that are collected 
at baseline (e.g., prior affective episodes, age at first symptom) are difficult to 
obtain accurately and can be confounded by recall errors. Second, the impact 
of the illness may not be simply cumulative. Third, it should be noted that 
approximately 60 -70% of our BD patients were studying or working more 
than half of the time, which is high compared with previous reports 
(MacQueen, Young, & Joffe, 2001). As mentioned above, our BD-cohort is 
actually more well-educated than the general Swedish population. Fourth, the 
association between different clinical and functional outcomes and cognitive 
performance within the normal range can be different from that at the high 
and low end of test scores. Fifth, the degree to which results obtained during 
cognitive testing are related to difficulties in naturalistic environments are also 
affected by the ecological validity of each test.  
Trajectory of cognitive functioning in bipolar disorder 
Cross-sectional studies (study I and II) cannot decide the causes of cognitive 
impairments as the directionality of the association between different 
outcomes cannot be discerned. Although some longitudinal studies exist, most 
are short-term, lack control group, include elderly patients, or used limited 
cognitive test batteries (Bora & Özerdem, 2017). Contrary to the assumption 
that cognitive impairments may be progressive (Berk, 2009), several studies 
have shown that changes in cognitive functioning over time do not differ 
between patients with BD and HC (Bora & Özerdem, 2017). Six studies have 
followed individuals with BD and HC for 5 or more years (Hinrichs et al., 
2017; Jiménez-López et al., 2019; Mora, Portella, Forcada, Vieta, & Mur, 2013; 
Ryan et al., 2016; Sanchez-Morla et al., 2018; Santos et al., 2014). By and large, 
these studies find that cognitive deficits in BD are stable over time. This is in 
line with our findings in study IV. Hinrichs and colleagues (2017) suggested 
that more stable cognitive function was associated with higher baseline 
intellectual ability, and that lower verbal IQ and education were related to 
increased cognitive decline in specific domains in BD. We did not specifically 
study that possibility in study IV. 
 
It is likely that different bipolar subgroups present with different cognitive 
trajectories. We investigated if BD subtypes, patients with manic and mixed 
  
 
68 
episodes during follow-up, as well as the cognitive subgroup identified in study 
II differed in their respective cognitive trajectory. We found no evidence for 
differences among these subgroups. On the contrary, we found that the 
cognitive functioning was surprisingly stable over a period of six years. For 
instance, the results on tests that characterized the cognitive subtype group in 
study II, e.g., memory aspects of Digit Symbol Coding, Claeson-Dahl, and the 
Rey Complex Figure Test were strikingly similar at follow-up compared with 
baseline six years earlier. And the difference relative the rest of the BD group 
remained. This result strengthens the notion that there is a cognitive subtype 
group in BD. When it comes to predicting the prospective illness course in 
study VI, we could not use baseline cognition to predict illness course over a 
period of six years. However, we cannot exclude that cognitive impairments 
are a risk factor for relapse with longer follow-up.  
 
If progressive cognitive impairment is not a general rule in BD, it remains to 
clarify at which point during the illness course cognitive impairments occur. 
One possibility is that cognitive impairment is a premorbid trait. Indeed, 
healthy first-degree relatives to patients with BD have been found to show 
similar but less pronounced cognitive impairments (Bora et al., 2009).  
 
A possible explanation to the lack of decline in cognitive functioning over time 
is that the follow-up period (six years) was too short to identify substantial 
changes. Therefore, we just started a 14-year follow up of our cohort. Another 
possible objection is that the group is too young and that the decline occurs 
in older age, above 60 years. Speaking against this notion, however, several 
studies have been carried out in an elderly population without showing a faster 
progressive decline in cognitive functioning in BD compared to HC 
(Gildengers et al., 2013; Schouws, Comijs, Dols, Beekman, & Stek, 2016; 
Schouws, Stek, Comijs, Dols, & Beekman, 2012).  
 
In summary, the majority of studies point in the direction of stabile cognitive 
functioning over time in individuals with BD. However, in light of the limited 
number of longitudinal studies in the field, one cannot dismiss the possibility 
that subgroups of individuals with BD have a progressively deteriorating 
course of cognitive functions. The topic is worthy of future studies 
considering that BD has been associated with higher risk of dementia (Diniz 
et al., 2017; Kessing & Andersen, 2004).  
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Personality traits in bipolar disorder  
The current view of BD as a categorical and episodic disorder could to some 
extent explain why the importance of personality traits for clinical and 
functional outcomes has been far less studied than cognitive functioning. It is, 
however, known that high levels of Neuroticism is strongly associated with 
common mental disorders (Ormel et al., 2013). In study V, we showed that BD 
I and II are associated with a personality profile comprising high scores on all 
traits of personality measured with SSP such as Neuroticism, Aggressiveness, 
and Extraversion (disinhibition). In line with Barnett (2011), we found high 
levels of Neuroticism in BD I.  This conflicts with the proposed state-trait 
continuum model in which BD I is suggested to present with near average 
scores on Neuroticism (Akiskal et al., 2006). We also identified individuals 
with extreme values on two or more traits. This begs the question what 
personality styles such combinations give rise to. According to the BAS 
Hypersensitive Model of Bipolar Spectrum Disorder, a highly responsive BAS 
in BD II predicts future hypomanic episodes. Yet, in study V the personality 
scores could not predict illness course over a two year follow up. Another 
study with similar objectives as study V also found that both subtypes of BD 
were similar with regard to personality as measured with the revised NEO-
FFI (Barnett et al., 2011). But they found that whereas BD was associated with 
high Neuroticism and Openness, Extraversion, Conscientiousness, and 
Agreeableness were low. Additionally, they fairly successfully predicted future 
illness course. It has been suggested that personality traits may reflect 
biologically based differences that cause diverse illness outcomes.  But the 
same biological base could also underlie illness outcomes without the two 
being related (Matthews et al., 2009). A direct comparison across Barnett and 
study V is limited by the use of different personality inventories. In contrast to 
NEO-FFI, SSP only covers those specific personality traits that impart 
vulnerability to psychiatric disorder. Therefore, the overall high personality 
scores are not surprising. Nevertheless, all studies within the field struggle with 
the methodological concerns of separating stable traits and transient states, 
which is a challenge in the case of BD as residual mood symptoms may exist 
in clinically stable patients. 
The cognition/personality interface 
Personality and general cognitive ability are usually considered separate 
constructs (Maltby et al., 2007). In study VI, we investigated if modeling 
personality and cognition together could add insights and new knowledge 
about cognitive functioning in BD. We found that in individuals with BD, 
Neuroticism was more tightly coupled to the performance of cognitive tests 
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than for HC. Yet, combining baseline cognition and personality measures had 
limited predictive power on prospective illness course and functional 
outcomes at six-year follow-up.  
 
The association between high Neuroticism and performance on cognitive test 
was not valid for HC. However, other studies have shown that anxiety 
symptoms among healthy elderly individuals predict subjective memory 
complaints (Balash et al., 2013) and objective episodic memory decline 
(Wetherell, Reynolds, Gatz, & Pedersen, 2002).   
 
We focused on trait anxiety embedded in the broad personality trait of 
Neuroticism and not state anxiety. Trait anxiety have been shown to be 
associated with attentional deficits when processing threatening stimuli 
(Eysenck et al., 1987). It has been established that highly neurotic never-
depressed individuals present negative affective processing biases in the 
cognitive domains of  perception, learning/memory, and reward/feedback, 
but not attention  (Roiser, Elliott, & Sahakian, 2012). The negative affective 
processing biases in highly neurotic individuals are qualitatively similar to 
those present in depressed states.  
 
High scores on Neuroticism also characterize p, the general psychopathology 
factor encapsulating the essential features of a person’s tendency to develop 
psychopathology (Caspi et al., 2014). In other words, p influences the risk of 
psychiatric symptoms. p is further characterized by low Agreeableness and 
Conscientiousness. Consequently, individuals high in p experience difficulties 
in regulation/control when dealing with self and others. Individuals high in p 
also showed less brain integrity in childhood (impairments on different 
cognitive tests and neurologic soft signs). 
 
Those high in Neuroticism also show problems regulating positive and 
negative affects. The capacity to regulate emotions is important for human 
adaptation. It “includes conscious and unconscious processes that increase or 
decrease the experience or expression of negative or positive emotions” 
(Gross & Thompson, 2007, p. 274) The function of emotion regulation in 
healthy individuals is to direct goal-oriented behavior and help individuals to 
recover from negative life effects. Individuals with larger working memory 
capacity have been  shown to be better at regulating their automatic behavior 
as affective information burden working memory (Robinson, Watkins, & 
Harmon-Jones, 2013).  
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It has also been demonstrated that high Neuroticism has clear adaptive costs 
with respect to impaired performance on demanding tasks in stressful 
environments. People with high Neuroticism are more prone to cognitive 
failures when dealing with everyday stressors. The importance of personality 
in the context of cognitive functioning is most likely characterized by a 
complex inter-relationship.  
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General discussion 
Cognitive impairment is a common feature of psychiatric disorder (Sha et al., 
2019). The most salient impairments found across distinct disorders are found 
in different aspects of attention (Millan et al., 2012). Besides, impairments in 
executive function, working memory, and salience processing are usually 
present in psychiatric disorders (Sha et al., 2019). These impairments share 
altered functional connectivity within and between core neurocognitive 
networks. 
 
We and others tend to believe that one should find something specific for the 
disorder being studied, in our case bipolar disorder. Alas, the idea of disorder-
specific correlates in the field of psychiatry are difficult to maintain when 
almost all psychiatric disorders present with various degrees of cognitive 
impairments along with difficulties with self-regulation and anxiety. The 
concept of a general psychopathology factor - p – rather imply that it is almost 
impossible to identify etiological factors that are exclusively a risk for a 
particular psychiatric disorder (Caspi et al., 2014). 
 
In the clinic setting, we tend to focus on the emotional aspects of BD and risk 
missing those patients with enduring cognitive problems. Despite the findings 
in this thesis, it is premature to rule out long-term trajectory of cognitive 
functioning in BD. If an individual gradually deteriorates in everyday 
functioning and in their ability to work, screening for impairments in multiple 
cognitive domains should be carried out. Cognitive function is also of 
relevance when monitoring the patient after starting a new drug, in particular 
antipsychotic drugs. It should be the psychiatrist’s duty to ask for cognitive 
side effects.  
 
Having said that, one cannot narrow-mindedly dwell on the importance of 
cognitive functioning measured with cognitive tests in order to understand the 
life of individuals with BD better. In everyday life, experience, wisdom, and 
creativity matters. Also, the ability to have close and deep relationship with 
significant others is of great importance.   
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Limitations and future work 
There are several limitations to consider in this work. First, all studies are 
limited by the lack of psychiatric control groups with other diagnosis than 
bipolar disorder, which would be important when studying illness features 
which are very likely to be transnosological. Second, even though the number 
of study subjects can be considered large for this field, an even larger N would 
have made it possible to carry out more subgroup analyses. A larger N had 
presumably made the PCA-models more well-fitted and valid. Third, in 
addition to the cognitive testing, our study subjects completed several 
questionnaires measuring cognitive symptoms. Here, we focused on the 
cognitive test measures but we would probably had gained a more complete 
picture of cognitive functioning in bipolar disorder by adding those 
questionnaires to the analyses. For example, study I to III might have benefitted 
from adding data from the Brown ADD scale as it might correspond better to 
executive dysfunction and real-world functioning. Fourth, when cognitive 
assessment is carried out in a clinical setting, the psychologist takes into 
consideration various qualitative aspects of the test performance and the 
individual´s subjective experience of cognitive impairments. This often leads 
to in-depth and targeted testing when uncertainties emerge. This dynamic 
process is absent when all study subjects are tested in a research setting that 
require that the same test battery is administered regardless of problems. Fifth, 
the psychometric approaches dominating both in the fields of personality and 
cognitive functioning could always be questioned based on the lack of validity 
of certain instruments used. It is furthermore challenging to use these 
instruments in individuals whose lives are characterized by changes in mood 
and activity level. It is not always straightforward to establish that someone is 
in their habitual state and that they are actually euthymic.  
 
The presentation of research findings in this field typically focuses on group 
means and p-values. We used multivariate projection methods to explore 
cognitive function and personality in bipolar disorder. Other methods to make 
similarities between groups more apparent have been suggested by Hanel et 
al., 2018. Another interesting approach is the network approach that offers a 
theoretical framework for thinking about psychopathology (Borsboom, 2017). 
The network approach hypothesizes that psychiatric disorders arise from 
causal interactions between symptoms in a network. There is a great need to 
compare cognitive profiles across several psychiatric disorders longitudinally 
in order to understand if any impairments can be considered to be diagnose 
specific. Moreover, clinically useful proxy markers for p would be valuable to 
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enable early identification of individuals at risk for developing 
psychopathology. 
 
Virtually all patients with bipolar disorder are prescribed some medication that 
might impact cognitive function. An interesting avenue for further research is 
therefore to examine whether it is possible to improve cognitive function by 
tapering some of these drugs or optimize the dose. In addition, there are 
promising functional and cognitive remediation programs that need to be 
further evaluated and implemented in the clinical treatment programs for BD 
along with psychosocial and psychological treatments.
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